| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP4 NPNT | 5.47e-13 | 188 | 80 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | THBS1 FBLN5 FBN1 PNLIPRP1 CELSR2 PRF1 ENPP2 LRP1 LTBP1 LTBP3 CBLB LTBP4 NOTCH1 EGFL6 PROS1 NPNT STAB1 | 5.34e-09 | 749 | 80 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | integrin binding | 5.02e-07 | 175 | 80 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | ethanol binding | 1.23e-06 | 6 | 80 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | structural molecule activity | THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP4 KRT38 KRT37 NPNT | 2.16e-06 | 891 | 80 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | growth factor binding | 3.06e-06 | 156 | 80 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 3.34e-06 | 26 | 80 | 4 | GO:0050431 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.33e-05 | 12 | 80 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.18e-05 | 14 | 80 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.34e-05 | 16 | 80 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | cytokine binding | 3.99e-05 | 157 | 80 | 6 | GO:0019955 | |
| GeneOntologyMolecularFunction | histone H3K27 trimethyltransferase activity | 4.74e-05 | 3 | 80 | 2 | GO:0140951 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 4.84e-05 | 18 | 80 | 3 | GO:0030169 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 7.82e-05 | 21 | 80 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.18e-04 | 24 | 80 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.51e-04 | 26 | 80 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.69e-04 | 27 | 80 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.33e-04 | 30 | 80 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | histone H3K27 methyltransferase activity | 2.35e-04 | 6 | 80 | 2 | GO:0046976 | |
| GeneOntologyMolecularFunction | ErbB-3 class receptor binding | 2.35e-04 | 6 | 80 | 2 | GO:0043125 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 3.70e-04 | 35 | 80 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 3.70e-04 | 35 | 80 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.78e-04 | 85 | 80 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.78e-04 | 85 | 80 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 6.46e-04 | 599 | 80 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | transcription regulator activator activity | 6.99e-04 | 10 | 80 | 2 | GO:0140537 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 7.29e-04 | 44 | 80 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | signaling receptor inhibitor activity | 8.30e-04 | 46 | 80 | 3 | GO:0030547 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.12e-03 | 51 | 80 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.20e-03 | 13 | 80 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 1.20e-03 | 13 | 80 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.57e-03 | 68 | 80 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 2.64e-03 | 596 | 80 | 8 | GO:0140678 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.68e-03 | 69 | 80 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 2.87e-03 | 20 | 80 | 2 | GO:0004675 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.87e-03 | 20 | 80 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.89e-03 | 891 | 80 | 10 | GO:0008270 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.91e-03 | 71 | 80 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | NAD binding | 3.15e-03 | 73 | 80 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.15e-03 | 73 | 80 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | LRR domain binding | 3.48e-03 | 22 | 80 | 2 | GO:0030275 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 4.45e-03 | 268 | 80 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 6.00e-03 | 29 | 80 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | protease binding | 6.05e-03 | 181 | 80 | 4 | GO:0002020 | |
| GeneOntologyMolecularFunction | receptor antagonist activity | 7.27e-03 | 32 | 80 | 2 | GO:0048019 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | PLXNA3 ERBB2 ERBB3 CELSR2 CSF3R CD27 TNFRSF8 LTBP1 LTBP4 NOTCH1 SORL1 TMEM63A | 7.39e-03 | 1353 | 80 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | alcohol binding | 8.00e-03 | 102 | 80 | 3 | GO:0043178 | |
| GeneOntologyMolecularFunction | laminin binding | 8.18e-03 | 34 | 80 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 8.18e-03 | 34 | 80 | 2 | GO:0046625 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 8.22e-03 | 103 | 80 | 3 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 8.66e-03 | 105 | 80 | 3 | GO:0008170 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 9.61e-03 | 323 | 80 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 9.64e-03 | 37 | 80 | 2 | GO:0022829 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SP8 ZBTB34 NANOGP8 KMT2D ZSCAN20 ZNF425 ZNF423 INSM1 NFXL1 MESP1 ATF2 NOTCH1 | 1.02e-02 | 1412 | 80 | 12 | GO:0000981 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | THBS1 AKAP4 NANOGP8 FBN1 ZNF423 WIF1 LRP1 LTBP1 LTBP3 FST LTBP4 ATF2 NOTCH1 NPNT SORL1 | 5.40e-10 | 482 | 81 | 15 | GO:0007178 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | THBS1 NANOGP8 FBN1 ZNF423 WIF1 LRP1 LTBP1 LTBP3 FST LTBP4 ATF2 NOTCH1 NPNT SORL1 | 1.89e-09 | 445 | 81 | 14 | GO:0141091 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | VEGFC THBS1 NANOGP8 FBN1 ZNF423 LRP1 SHISA2 LTBP1 FST LTBP4 NOTCH1 NPNT SORL1 | 7.32e-09 | 412 | 81 | 13 | GO:0090287 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | VEGFC ERBB2 THBS1 ERBB3 AKAP4 NANOGP8 FBN1 ZNF423 WIF1 LRP1 SHISA2 LTBP1 LTBP3 FST CBLB LTBP4 ATF2 NOTCH1 NPNT SORL1 | 2.17e-08 | 1186 | 81 | 20 | GO:0007167 |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 5.83e-08 | 3 | 81 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | PLXNA3 ERBB2 THBS1 ERBB3 CELSR2 CD27 ENPP2 LAMA1 LRP1 LAMA2 ADAMTS18 LAMC1 CBLB TACSTD2 NOTCH1 EGFL6 NPNT | 9.18e-08 | 927 | 81 | 17 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | THBS1 NANOGP8 FBN1 ZNF423 LRP1 LTBP1 FST LTBP4 NOTCH1 NPNT SORL1 | 1.11e-07 | 347 | 81 | 11 | GO:0090092 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | VEGFC ERBB2 THBS1 NANOGP8 FBN1 ZNF423 LRP1 SHISA2 LTBP1 LTBP3 FST LTBP4 ATF2 NOTCH1 NPNT SORL1 | 1.64e-07 | 850 | 81 | 16 | GO:0071363 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | FBLN5 PXDN LAMA1 LRP1 LAMA2 ADAMTS18 LAMC1 LTBP4 NOTCH1 EGFL6 NPNT | 2.54e-07 | 377 | 81 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | FBLN5 PXDN LAMA1 LRP1 LAMA2 ADAMTS18 LAMC1 LTBP4 NOTCH1 EGFL6 NPNT | 2.61e-07 | 378 | 81 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | FBLN5 PXDN LAMA1 LRP1 LAMA2 ADAMTS18 LAMC1 LTBP4 NOTCH1 EGFL6 NPNT | 2.68e-07 | 379 | 81 | 11 | GO:0045229 |
| GeneOntologyBiologicalProcess | response to growth factor | VEGFC ERBB2 THBS1 NANOGP8 FBN1 ZNF423 LRP1 SHISA2 LTBP1 LTBP3 FST LTBP4 ATF2 NOTCH1 NPNT SORL1 | 2.74e-07 | 883 | 81 | 16 | GO:0070848 |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 5.80e-07 | 5 | 81 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | PLXNA3 ERBB2 THBS1 ERBB3 ENPP2 LRP1 ADAMTS18 CBLB TACSTD2 NOTCH1 | 2.09e-06 | 375 | 81 | 10 | GO:0007162 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 4.61e-06 | 410 | 81 | 10 | GO:0031589 | |
| GeneOntologyBiologicalProcess | tube development | VEGFC ERBB2 THBS1 FBLN5 FBN1 PXDN MTHFD1 LAMA1 LRP1 MUC19 LTBP3 MESP1 C6 TACSTD2 ATF2 NOTCH1 NPNT STAB1 | 6.43e-06 | 1402 | 81 | 18 | GO:0035295 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | VEGFC THBS1 FRAS1 CSF3R MTHFD1 LAMA1 MUC19 LAMA2 LAMC1 LAMC2 LTBP3 MESP1 FST TACSTD2 ATF2 NOTCH1 NPNT | 7.00e-06 | 1269 | 81 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 9.41e-06 | 11 | 81 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 1.07e-05 | 74 | 81 | 5 | GO:0010812 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 1.25e-05 | 197 | 81 | 7 | GO:0030509 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.29e-05 | 131 | 81 | 6 | GO:0030510 | |
| GeneOntologyBiologicalProcess | blood vessel development | VEGFC ERBB2 THBS1 FBLN5 PXDN LAMA1 WIF1 LRP1 LTBP1 MESP1 C6 ATF2 NOTCH1 STAB1 | 1.40e-05 | 929 | 81 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | axon guidance | 1.62e-05 | 285 | 81 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.66e-05 | 286 | 81 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 2.00e-05 | 84 | 81 | 5 | GO:1903053 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 2.06e-05 | 14 | 81 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | response to BMP | 2.19e-05 | 215 | 81 | 7 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 2.19e-05 | 215 | 81 | 7 | GO:0071773 | |
| GeneOntologyBiologicalProcess | vasculature development | VEGFC ERBB2 THBS1 FBLN5 PXDN LAMA1 WIF1 LRP1 LTBP1 MESP1 C6 ATF2 NOTCH1 STAB1 | 2.24e-05 | 969 | 81 | 14 | GO:0001944 |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.40e-05 | 218 | 81 | 7 | GO:0090101 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 2.42e-05 | 43 | 81 | 4 | GO:0071711 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 2.77e-05 | 150 | 81 | 6 | GO:0090288 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | VEGFC ERBB2 THBS1 FBLN5 PXDN MTHFD1 LAMA1 LRP1 MESP1 C6 TACSTD2 ATF2 NOTCH1 NPNT STAB1 | 2.80e-05 | 1125 | 81 | 15 | GO:0035239 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | VEGFC PLXNA3 CD27 ENPP2 INSM1 LAMA1 WIF1 LRP1 LAMA2 LAMC1 LTBP3 MESP1 TACSTD2 NOTCH1 NPNT | 3.30e-05 | 1141 | 81 | 15 | GO:0045597 |
| GeneOntologyBiologicalProcess | circulatory system development | VEGFC ERBB2 THBS1 ERBB3 FBLN5 FBN1 PXDN MTHFD1 LAMA1 WIF1 LRP1 LTBP1 MESP1 C6 ATF2 NOTCH1 STAB1 | 3.66e-05 | 1442 | 81 | 17 | GO:0072359 |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 3.81e-05 | 17 | 81 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 3.81e-05 | 17 | 81 | 3 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 4.56e-05 | 18 | 81 | 3 | GO:0006067 | |
| GeneOntologyBiologicalProcess | response to testosterone | 5.58e-05 | 53 | 81 | 4 | GO:0033574 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 6.13e-05 | 106 | 81 | 5 | GO:0051149 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 6.33e-05 | 254 | 81 | 7 | GO:0010810 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | VEGFC PLXNA3 ERBB2 THBS1 FBLN5 NANOGP8 FBN1 LTBP3 MESP1 FST TACSTD2 ATF2 NOTCH1 SORL1 STAB1 | 7.09e-05 | 1220 | 81 | 15 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | VEGFC PLXNA3 ERBB2 THBS1 FBLN5 ENPP2 LRP1 MESP1 C6 LRRC4C TACSTD2 ATF2 NOTCH1 STAB1 | 8.05e-05 | 1090 | 81 | 14 | GO:0022603 |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 8.52e-05 | 59 | 81 | 4 | GO:0085029 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 9.09e-05 | 4 | 81 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 9.09e-05 | 4 | 81 | 2 | GO:0042664 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 9.76e-05 | 23 | 81 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 9.76e-05 | 23 | 81 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.06e-04 | 276 | 81 | 7 | GO:0007179 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.09e-04 | 192 | 81 | 6 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.19e-04 | 195 | 81 | 6 | GO:1903844 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 1.51e-04 | 5 | 81 | 2 | GO:0042663 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | VEGFC FRAS1 MTHFD1 LAMA1 LAMC1 MESP1 FST TACSTD2 NOTCH1 NPNT | 1.52e-04 | 619 | 81 | 10 | GO:0002009 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | VEGFC FRAS1 NANOGP8 MTHFD1 LAMA1 LAMC1 MESP1 FST TACSTD2 NOTCH1 NPNT | 1.63e-04 | 750 | 81 | 11 | GO:0048729 |
| GeneOntologyBiologicalProcess | heart development | ERBB2 THBS1 ERBB3 FBN1 MTHFD1 WIF1 LRP1 LTBP1 MESP1 ATF2 NOTCH1 | 1.77e-04 | 757 | 81 | 11 | GO:0007507 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | PLXNA3 ERBB2 THBS1 FBLN5 FBN1 ZNF423 ADAMTS18 LTBP3 CBLB TACSTD2 ATF2 NOTCH1 HCRT PROS1 SORL1 STAB1 | 1.89e-04 | 1488 | 81 | 16 | GO:0051241 |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | VEGFC ERBB2 THBS1 ERBB3 FBLN5 NANOGP8 KMT2D ENPP2 INSM1 LAMC1 LAMC2 LTBP3 ATF2 NOTCH1 | 2.02e-04 | 1190 | 81 | 14 | GO:0008284 |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 2.26e-04 | 6 | 81 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | aldehyde biosynthetic process | 2.42e-04 | 31 | 81 | 3 | GO:0046184 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 2.78e-04 | 80 | 81 | 4 | GO:0030514 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell chemotaxis | 3.16e-04 | 7 | 81 | 2 | GO:2001027 | |
| GeneOntologyBiologicalProcess | growth involved in heart morphogenesis | 3.16e-04 | 7 | 81 | 2 | GO:0003241 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 3.20e-04 | 83 | 81 | 4 | GO:0060976 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | VEGFC ERBB2 THBS1 FBLN5 PXDN LAMA1 LRP1 C6 ATF2 NOTCH1 STAB1 | 3.40e-04 | 817 | 81 | 11 | GO:0048514 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PLXNA3 ERBB2 CELSR2 ENPP2 LAMA1 LRP1 LAMA2 LAMC1 LAMC2 LRRC4C NOTCH1 | 3.47e-04 | 819 | 81 | 11 | GO:0120039 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 3.54e-04 | 336 | 81 | 7 | GO:0071560 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PLXNA3 ERBB2 CELSR2 ENPP2 LAMA1 LRP1 LAMA2 LAMC1 LAMC2 LRRC4C NOTCH1 | 3.73e-04 | 826 | 81 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | axonogenesis | 3.73e-04 | 566 | 81 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | endoderm development | 4.01e-04 | 88 | 81 | 4 | GO:0007492 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 4.01e-04 | 343 | 81 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 4.18e-04 | 89 | 81 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 4.20e-04 | 8 | 81 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell proliferation | 4.20e-04 | 8 | 81 | 2 | GO:1902462 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 4.20e-04 | 8 | 81 | 2 | GO:0009996 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 4.40e-04 | 579 | 81 | 9 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 4.55e-04 | 91 | 81 | 4 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 4.94e-04 | 93 | 81 | 4 | GO:1900046 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 5.15e-04 | 94 | 81 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 5.19e-04 | 40 | 81 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | hair follicle morphogenesis | 5.19e-04 | 40 | 81 | 3 | GO:0031069 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 5.57e-04 | 96 | 81 | 4 | GO:0050818 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 6.09e-04 | 368 | 81 | 7 | GO:0030111 | |
| GeneOntologyBiologicalProcess | regulation of stem cell differentiation | 6.26e-04 | 99 | 81 | 4 | GO:2000736 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-matrix adhesion | 6.43e-04 | 43 | 81 | 3 | GO:0001953 | |
| GeneOntologyBiologicalProcess | cardiac ventricle formation | 6.72e-04 | 10 | 81 | 2 | GO:0003211 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 6.72e-04 | 10 | 81 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PLXNA3 ERBB2 CELSR2 LAMA1 LRP1 LAMA2 LAMC1 LAMC2 LRRC4C NOTCH1 | 6.81e-04 | 748 | 81 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | bone growth | 7.35e-04 | 45 | 81 | 3 | GO:0098868 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 7.81e-04 | 105 | 81 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | epidermis morphogenesis | 7.84e-04 | 46 | 81 | 3 | GO:0048730 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 8.19e-04 | 11 | 81 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 8.19e-04 | 11 | 81 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal stem cell proliferation | 8.19e-04 | 11 | 81 | 2 | GO:1902460 | |
| GeneOntologyBiologicalProcess | elastic fiber assembly | 8.19e-04 | 11 | 81 | 2 | GO:0048251 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 8.35e-04 | 47 | 81 | 3 | GO:0046164 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 8.68e-04 | 108 | 81 | 4 | GO:0007044 | |
| GeneOntologyBiologicalProcess | axon development | 9.19e-04 | 642 | 81 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 9.44e-04 | 516 | 81 | 8 | GO:0016055 | |
| GeneOntologyBiologicalProcess | autonomic nervous system development | 1.00e-03 | 50 | 81 | 3 | GO:0048483 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 1.03e-03 | 195 | 81 | 5 | GO:0030178 | |
| GeneOntologyCellularComponent | basement membrane | 4.18e-11 | 122 | 81 | 10 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMB4 THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 EGFL6 NPNT | 1.71e-10 | 530 | 81 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 ADAMTS18 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 EGFL6 NPNT | 4.47e-10 | 656 | 81 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 ADAMTS18 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 EGFL6 NPNT | 4.69e-10 | 658 | 81 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | laminin complex | 6.60e-06 | 10 | 81 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | ERBB3:ERBB2 complex | 1.48e-05 | 2 | 81 | 2 | GO:0038143 | |
| GeneOntologyCellularComponent | microfibril | 1.56e-05 | 13 | 81 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 3.66e-05 | 17 | 81 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | laminin-1 complex | 4.44e-05 | 3 | 81 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.33e-04 | 67 | 81 | 4 | GO:0031093 | |
| GeneOntologyCellularComponent | platelet alpha granule | 4.70e-04 | 93 | 81 | 4 | GO:0031091 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.13e-03 | 13 | 81 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.56e-03 | 59 | 81 | 3 | GO:0098636 | |
| HumanPheno | Multiple bladder diverticula | 4.11e-06 | 5 | 39 | 3 | HP:0012619 | |
| MousePheno | abnormal ethanol metabolism | 2.48e-06 | 6 | 71 | 3 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 4.33e-06 | 7 | 71 | 3 | MP:0005444 | |
| MousePheno | abnormal Schwann cell morphology | 3.56e-05 | 37 | 71 | 4 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 3.56e-05 | 37 | 71 | 4 | MP:0001105 | |
| MousePheno | abnormal respiration | ERBB2 FRAS1 ERBB3 FBN1 INSM1 LAMA2 ADAMTS18 LAMC2 FST LTBP4 ATF2 HCRT | 4.26e-05 | 598 | 71 | 12 | MP:0001943 |
| MousePheno | abnormal aorta elastic fiber morphology | 4.39e-05 | 14 | 71 | 3 | MP:0003211 | |
| MousePheno | abnormal basement membrane morphology | 4.86e-05 | 40 | 71 | 4 | MP:0004272 | |
| MousePheno | abnormal vitamin metabolism | 5.47e-05 | 15 | 71 | 3 | MP:0013244 | |
| MousePheno | abnormal vitamin or vitamin cofactor metabolism | 5.47e-05 | 15 | 71 | 3 | MP:0013274 | |
| MousePheno | abnormal vitamin A metabolism | 5.47e-05 | 15 | 71 | 3 | MP:0011233 | |
| MousePheno | enhanced behavioral response to alcohol | 6.71e-05 | 16 | 71 | 3 | MP:0009751 | |
| MousePheno | absent cerebellum vermis | 7.61e-05 | 3 | 71 | 2 | MP:0000865 | |
| MousePheno | abnormal cerebellar plate morphology | 7.61e-05 | 3 | 71 | 2 | MP:0000856 | |
| MousePheno | abnormal Schwann cell precursor morphology | 7.61e-05 | 3 | 71 | 2 | MP:0004074 | |
| MousePheno | decreased Schwann cell precursor number | 7.61e-05 | 3 | 71 | 2 | MP:0004075 | |
| MousePheno | abnormal neuron number | 9.60e-05 | 456 | 71 | 10 | MP:0008946 | |
| MousePheno | abnormal respiratory system physiology | ERBB2 THBS1 FRAS1 ERBB3 FBLN5 FBN1 INSM1 LAMA2 ADAMTS18 LAMC2 FST LTBP4 ATF2 HCRT | 1.41e-04 | 897 | 71 | 14 | MP:0002133 |
| MousePheno | abnormal extracellular matrix morphology | 1.52e-04 | 100 | 71 | 5 | MP:0013258 | |
| MousePheno | abnormal respiratory system morphology | SP8 THBS1 FRAS1 FBLN5 FBN1 PRF1 ZNF423 INSM1 ADAMTS18 CUL9 LAMC1 LTBP3 FST LTBP4 ATF2 | 1.63e-04 | 1027 | 71 | 15 | MP:0002132 |
| MousePheno | abnormal aorta elastic tissue morphology | 1.80e-04 | 22 | 71 | 3 | MP:0009862 | |
| MousePheno | abnormal ascending aorta morphology | 1.80e-04 | 22 | 71 | 3 | MP:0009867 | |
| MousePheno | kinked neural tube | 1.97e-04 | 57 | 71 | 4 | MP:0003400 | |
| MousePheno | decreased respiration | 2.21e-04 | 170 | 71 | 6 | MP:0014274 | |
| MousePheno | small maxilla | 2.25e-04 | 59 | 71 | 4 | MP:0004540 | |
| MousePheno | abnormal blood vessel elastic tissue morphology | 2.35e-04 | 24 | 71 | 3 | MP:0006083 | |
| MousePheno | abnormal behavioral response to alcohol | 2.35e-04 | 24 | 71 | 3 | MP:0020157 | |
| MousePheno | abnormal blood circulation | VEGFC ERBB2 THBS1 FRAS1 ERBB3 FBLN5 FBN1 VWF ENPP2 LRP1 LAMC1 NOTCH1 PROS1 | 2.90e-04 | 845 | 71 | 13 | MP:0002128 |
| MousePheno | abnormal basal lamina morphology | 3.77e-04 | 6 | 71 | 2 | MP:0004273 | |
| MousePheno | abnormal heart valve physiology | 4.62e-04 | 30 | 71 | 3 | MP:0011926 | |
| MousePheno | abnormal neuron differentiation | 4.80e-04 | 275 | 71 | 7 | MP:0009937 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | VEGFC SP8 ERBB2 FRAS1 ERBB3 FBN1 ZNF423 INSM1 LRP1 LAMC1 LAMC2 LTBP1 FST ATF2 PROS1 NPNT | 5.09e-04 | 1269 | 71 | 16 | MP:0011111 |
| MousePheno | abnormal respiratory conducting tube morphology | 6.89e-04 | 79 | 71 | 4 | MP:0004391 | |
| MousePheno | abnormal retina inner limiting membrane morphology | 6.98e-04 | 8 | 71 | 2 | MP:0010235 | |
| MousePheno | internal hemorrhage | 7.45e-04 | 387 | 71 | 8 | MP:0001634 | |
| Domain | EGF-like_dom | THBS1 FRAS1 FBLN5 FBN1 CELSR2 ADAM18 PRF1 LAMA1 WIF1 LRP1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 C6 LTBP4 NOTCH1 EGFL6 PROS1 NPNT SORL1 STAB1 | 9.30e-25 | 249 | 80 | 23 | IPR000742 |
| Domain | EGF-like_CS | LAMB4 THBS1 FBLN5 FBN1 CELSR2 ADAM18 PRF1 LAMA1 WIF1 LRP1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 C6 LTBP4 NOTCH1 EGFL6 PROS1 NPNT SORL1 STAB1 | 2.78e-24 | 261 | 80 | 23 | IPR013032 |
| Domain | EGF_2 | LAMB4 THBS1 FBLN5 FBN1 CELSR2 ADAM18 PRF1 LAMA1 WIF1 LRP1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 C6 LTBP4 NOTCH1 EGFL6 PROS1 NPNT SORL1 STAB1 | 3.96e-24 | 265 | 80 | 23 | PS01186 |
| Domain | EGF_1 | LAMB4 THBS1 FBLN5 FBN1 CELSR2 ADAM18 PRF1 LAMA1 WIF1 LRP1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 C6 LTBP4 NOTCH1 EGFL6 PROS1 NPNT STAB1 | 5.07e-23 | 255 | 80 | 22 | PS00022 |
| Domain | Growth_fac_rcpt_ | ERBB2 FRAS1 ERBB3 FBLN5 FBN1 CELSR2 LAMA1 LRP1 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 NOTCH1 EGFL6 PROS1 NPNT STAB1 | 3.27e-21 | 156 | 80 | 18 | IPR009030 |
| Domain | EGF | THBS1 FRAS1 FBLN5 FBN1 CELSR2 LAMA1 WIF1 LRP1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 NOTCH1 EGFL6 PROS1 NPNT SORL1 STAB1 | 7.93e-21 | 235 | 80 | 20 | SM00181 |
| Domain | EGF_3 | THBS1 FBLN5 FBN1 CELSR2 ADAM18 PRF1 WIF1 LRP1 LTBP1 LTBP3 C6 LTBP4 NOTCH1 EGFL6 PROS1 NPNT SORL1 STAB1 | 5.77e-18 | 235 | 80 | 18 | PS50026 |
| Domain | EGF_CA | THBS1 FBLN5 FBN1 CELSR2 LRP1 LTBP1 LTBP3 LTBP4 NOTCH1 EGFL6 PROS1 NPNT STAB1 | 4.47e-15 | 122 | 80 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | THBS1 FBLN5 FBN1 CELSR2 LRP1 LTBP1 LTBP3 LTBP4 NOTCH1 EGFL6 PROS1 NPNT STAB1 | 5.54e-15 | 124 | 80 | 13 | IPR001881 |
| Domain | EGF_CA | THBS1 FBLN5 FBN1 LRP1 LTBP1 LTBP3 LTBP4 NOTCH1 EGFL6 PROS1 NPNT | 8.25e-14 | 86 | 80 | 11 | PF07645 |
| Domain | ASX_HYDROXYL | FBLN5 FBN1 CELSR2 LRP1 LTBP1 LTBP3 LTBP4 NOTCH1 EGFL6 PROS1 NPNT | 4.55e-13 | 100 | 80 | 11 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FBLN5 FBN1 CELSR2 LRP1 LTBP1 LTBP3 LTBP4 NOTCH1 EGFL6 PROS1 NPNT | 8.75e-13 | 106 | 80 | 11 | IPR000152 |
| Domain | EGF_Ca-bd_CS | 1.08e-11 | 97 | 80 | 10 | IPR018097 | |
| Domain | EGF_CA | 1.33e-11 | 99 | 80 | 10 | PS01187 | |
| Domain | EGF_LAM_2 | 3.80e-11 | 30 | 80 | 7 | PS50027 | |
| Domain | EGF_LAM_1 | 3.80e-11 | 30 | 80 | 7 | PS01248 | |
| Domain | Laminin_EGF | 1.24e-10 | 35 | 80 | 7 | PF00053 | |
| Domain | EGF_Lam | 1.24e-10 | 35 | 80 | 7 | SM00180 | |
| Domain | TB | 1.58e-10 | 9 | 80 | 5 | PS51364 | |
| Domain | TB_dom | 1.58e-10 | 9 | 80 | 5 | IPR017878 | |
| Domain | Laminin_EGF | 2.29e-10 | 38 | 80 | 7 | IPR002049 | |
| Domain | TB | 1.08e-08 | 7 | 80 | 4 | PF00683 | |
| Domain | LAMININ_IVA | 2.16e-08 | 8 | 80 | 4 | PS51115 | |
| Domain | Laminin_B | 2.16e-08 | 8 | 80 | 4 | PF00052 | |
| Domain | - | 2.16e-08 | 8 | 80 | 4 | 3.90.290.10 | |
| Domain | LamB | 2.16e-08 | 8 | 80 | 4 | SM00281 | |
| Domain | Laminin_IV | 2.16e-08 | 8 | 80 | 4 | IPR000034 | |
| Domain | cEGF | 7.79e-08 | 26 | 80 | 5 | IPR026823 | |
| Domain | cEGF | 7.79e-08 | 26 | 80 | 5 | PF12662 | |
| Domain | Laminin_N | 5.46e-07 | 16 | 80 | 4 | IPR008211 | |
| Domain | LAMININ_NTER | 5.46e-07 | 16 | 80 | 4 | PS51117 | |
| Domain | Laminin_N | 5.46e-07 | 16 | 80 | 4 | PF00055 | |
| Domain | LamNT | 5.46e-07 | 16 | 80 | 4 | SM00136 | |
| Domain | VWC | 5.71e-07 | 38 | 80 | 5 | SM00214 | |
| Domain | VWFC_2 | 5.71e-07 | 38 | 80 | 5 | PS50184 | |
| Domain | VWF_dom | 9.54e-07 | 42 | 80 | 5 | IPR001007 | |
| Domain | EGF | 1.14e-06 | 126 | 80 | 7 | PF00008 | |
| Domain | ADH_Zn_CS | 4.17e-06 | 8 | 80 | 3 | IPR002328 | |
| Domain | ADH_ZINC | 4.17e-06 | 8 | 80 | 3 | PS00059 | |
| Domain | Laminin_G | 4.87e-06 | 58 | 80 | 5 | IPR001791 | |
| Domain | hEGF | 5.91e-06 | 28 | 80 | 4 | PF12661 | |
| Domain | VWC | 5.91e-06 | 28 | 80 | 4 | PF00093 | |
| Domain | Laminin_G_1 | 1.22e-05 | 11 | 80 | 3 | PF00054 | |
| Domain | VWFC_1 | 1.66e-05 | 36 | 80 | 4 | PS01208 | |
| Domain | LAM_G_DOMAIN | 2.06e-05 | 38 | 80 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 2.54e-05 | 40 | 80 | 4 | PF02210 | |
| Domain | LamG | 3.72e-05 | 44 | 80 | 4 | SM00282 | |
| Domain | ADH_N | 4.07e-05 | 16 | 80 | 3 | PF08240 | |
| Domain | PKS_ER | 4.07e-05 | 16 | 80 | 3 | SM00829 | |
| Domain | PKS_ER | 4.07e-05 | 16 | 80 | 3 | IPR020843 | |
| Domain | ADH_N | 4.07e-05 | 16 | 80 | 3 | IPR013154 | |
| Domain | ConA-like_dom | 4.26e-05 | 219 | 80 | 7 | IPR013320 | |
| Domain | - | 5.45e-05 | 95 | 80 | 5 | 2.60.120.200 | |
| Domain | - | 5.90e-05 | 18 | 80 | 3 | 3.90.180.10 | |
| Domain | Furin_repeat | 5.90e-05 | 18 | 80 | 3 | IPR006212 | |
| Domain | FU | 5.90e-05 | 18 | 80 | 3 | SM00261 | |
| Domain | SET_dom | 6.19e-05 | 50 | 80 | 4 | IPR001214 | |
| Domain | SET | 6.19e-05 | 50 | 80 | 4 | PS50280 | |
| Domain | VWC_out | 6.98e-05 | 19 | 80 | 3 | SM00215 | |
| Domain | ADH_zinc_N | 6.98e-05 | 19 | 80 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 6.98e-05 | 19 | 80 | 3 | IPR002085 | |
| Domain | ADH_C | 6.98e-05 | 19 | 80 | 3 | IPR013149 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 1.08e-04 | 4 | 80 | 2 | IPR016245 | |
| Domain | EGF_extracell | 1.27e-04 | 60 | 80 | 4 | IPR013111 | |
| Domain | EGF_2 | 1.27e-04 | 60 | 80 | 4 | PF07974 | |
| Domain | GroES-like | 1.44e-04 | 24 | 80 | 3 | IPR011032 | |
| Domain | Laminin_aI | 1.80e-04 | 5 | 80 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.80e-04 | 5 | 80 | 2 | PF06008 | |
| Domain | Laminin_II | 1.80e-04 | 5 | 80 | 2 | PF06009 | |
| Domain | Laminin_domII | 1.80e-04 | 5 | 80 | 2 | IPR010307 | |
| Domain | TNFR | 1.83e-04 | 26 | 80 | 3 | SM00208 | |
| Domain | GF_recep_IV | 2.69e-04 | 6 | 80 | 2 | PF14843 | |
| Domain | GF_recep_IV | 2.69e-04 | 6 | 80 | 2 | IPR032778 | |
| Domain | MACPF_CS | 2.69e-04 | 6 | 80 | 2 | IPR020863 | |
| Domain | Furin-like | 3.75e-04 | 7 | 80 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 3.75e-04 | 7 | 80 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 3.75e-04 | 7 | 80 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 3.75e-04 | 7 | 80 | 2 | PF01030 | |
| Domain | MACPF_2 | 3.75e-04 | 7 | 80 | 2 | PS51412 | |
| Domain | - | 3.75e-04 | 7 | 80 | 2 | 3.80.20.20 | |
| Domain | MACPF_1 | 3.75e-04 | 7 | 80 | 2 | PS00279 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 3.76e-04 | 33 | 80 | 3 | IPR001368 | |
| Domain | LDLR_class-A_CS | 6.67e-04 | 40 | 80 | 3 | IPR023415 | |
| Domain | Galactose-bd-like | 7.10e-04 | 94 | 80 | 4 | IPR008979 | |
| Domain | SET | 7.17e-04 | 41 | 80 | 3 | PF00856 | |
| Domain | MAC_perforin | 7.97e-04 | 10 | 80 | 2 | IPR001862 | |
| Domain | Ldl_recept_a | 9.43e-04 | 45 | 80 | 3 | PF00057 | |
| Domain | MACPF | 9.72e-04 | 11 | 80 | 2 | PF01823 | |
| Domain | - | 9.72e-04 | 11 | 80 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 9.72e-04 | 11 | 80 | 2 | IPR023413 | |
| Domain | SET | 1.01e-03 | 46 | 80 | 3 | SM00317 | |
| Domain | LDLRA_1 | 1.14e-03 | 48 | 80 | 3 | PS01209 | |
| Domain | TIL | 1.16e-03 | 12 | 80 | 2 | PF01826 | |
| Domain | MACPF | 1.16e-03 | 12 | 80 | 2 | SM00457 | |
| Domain | MACPF | 1.16e-03 | 12 | 80 | 2 | IPR020864 | |
| Domain | C8 | 1.16e-03 | 12 | 80 | 2 | PF08742 | |
| Domain | LDLRA_2 | 1.21e-03 | 49 | 80 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.21e-03 | 49 | 80 | 3 | IPR002172 | |
| Domain | LDLa | 1.21e-03 | 49 | 80 | 3 | SM00192 | |
| Domain | Unchr_dom_Cys-rich | 1.37e-03 | 13 | 80 | 2 | IPR014853 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | THBS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 ADAMTS18 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 | 1.56e-09 | 300 | 68 | 13 | M610 |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.75e-08 | 66 | 68 | 7 | M18 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 3.42e-08 | 8 | 68 | 4 | M47850 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 8.10e-08 | 46 | 68 | 6 | M239 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.50e-07 | 84 | 68 | 7 | M7098 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.59e-07 | 11 | 68 | 4 | M158 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 3.71e-07 | 59 | 68 | 6 | M39886 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.09e-07 | 32 | 68 | 5 | MM14854 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.46e-07 | 199 | 68 | 9 | M7253 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 8.70e-07 | 37 | 68 | 5 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.14e-06 | 39 | 68 | 5 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.11e-06 | 44 | 68 | 5 | M26969 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.04e-06 | 84 | 68 | 6 | M3228 | |
| Pathway | WP_FOCAL_ADHESION | 3.09e-06 | 187 | 68 | 8 | MM15913 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.28e-06 | 325 | 68 | 10 | M12868 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.77e-06 | 339 | 68 | 10 | M39736 | |
| Pathway | WP_FOCAL_ADHESION | 4.90e-06 | 199 | 68 | 8 | M39402 | |
| Pathway | REACTOME_ABACAVIR_ADME | 5.91e-06 | 8 | 68 | 3 | MM14869 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 6.63e-06 | 96 | 68 | 6 | M39834 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.20e-06 | 59 | 68 | 5 | M27218 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.23e-05 | 30 | 68 | 4 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.23e-05 | 30 | 68 | 4 | M27216 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 1.26e-05 | 10 | 68 | 3 | MM15833 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.37e-05 | 302 | 68 | 9 | M39719 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 1.41e-05 | 31 | 68 | 4 | M39714 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.60e-05 | 66 | 68 | 5 | MM15925 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.72e-05 | 11 | 68 | 3 | MM15405 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.82e-05 | 33 | 68 | 4 | M39503 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 2.29e-05 | 12 | 68 | 3 | M14663 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.51e-05 | 326 | 68 | 9 | MM15917 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.23e-05 | 38 | 68 | 4 | MM14874 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.23e-05 | 258 | 68 | 8 | MM14572 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.38e-05 | 41 | 68 | 4 | M27778 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 4.69e-05 | 15 | 68 | 3 | M39717 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 7.55e-05 | 47 | 68 | 4 | M646 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.21e-04 | 53 | 68 | 4 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.40e-04 | 55 | 68 | 4 | M39351 | |
| Pathway | WP_CANCER_PATHWAYS | VEGFC LAMB4 ERBB2 TRAF1 CSF3R LAMA1 LAMA2 LAMC1 LAMC2 NOTCH1 | 1.48e-04 | 507 | 68 | 10 | M48302 |
| Pathway | REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING | 2.27e-04 | 5 | 68 | 2 | M26937 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.58e-04 | 118 | 68 | 5 | MM15588 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 3.23e-04 | 28 | 68 | 3 | MM15188 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.97e-04 | 30 | 68 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.97e-04 | 30 | 68 | 3 | MM15812 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.14e-04 | 77 | 68 | 4 | MM14670 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.67e-04 | 79 | 68 | 4 | M27643 | |
| Pathway | KEGG_PRION_DISEASES | 6.29e-04 | 35 | 68 | 3 | M13036 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 9.84e-04 | 532 | 68 | 9 | M27870 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 1.01e-03 | 10 | 68 | 2 | MM1545 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.07e-03 | 161 | 68 | 5 | M27871 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 1.08e-03 | 42 | 68 | 3 | M16743 | |
| Pathway | KEGG_BLADDER_CANCER | 1.08e-03 | 42 | 68 | 3 | M19096 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 1.08e-03 | 42 | 68 | 3 | M699 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.09e-03 | 94 | 68 | 4 | M1041 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.15e-03 | 43 | 68 | 3 | M53 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.18e-03 | 96 | 68 | 4 | M39581 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.23e-03 | 11 | 68 | 2 | MM15478 | |
| Pathway | WP_RETINOL_METABOLISM | 1.23e-03 | 44 | 68 | 3 | MM15851 | |
| Pathway | WP_HEART_DEVELOPMENT | 1.40e-03 | 46 | 68 | 3 | MM15884 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 1.47e-03 | 12 | 68 | 2 | M22020 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.47e-03 | 12 | 68 | 2 | MM14550 | |
| Pathway | WP_HEART_DEVELOPMENT | 1.50e-03 | 47 | 68 | 3 | M39610 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.69e-03 | 49 | 68 | 3 | MM15186 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.73e-03 | 13 | 68 | 2 | M27729 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.73e-03 | 13 | 68 | 2 | MM15320 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.73e-03 | 13 | 68 | 2 | M549 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 1.95e-03 | 110 | 68 | 4 | MM16642 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.01e-03 | 14 | 68 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 2.01e-03 | 14 | 68 | 2 | MM14531 | |
| Pathway | WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER | 2.12e-03 | 53 | 68 | 3 | M39688 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 2.31e-03 | 15 | 68 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 2.31e-03 | 15 | 68 | 2 | M27608 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 2.35e-03 | 55 | 68 | 3 | M47952 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.63e-03 | 16 | 68 | 2 | M47424 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.63e-03 | 16 | 68 | 2 | M570 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 2.74e-03 | 58 | 68 | 3 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 2.88e-03 | 59 | 68 | 3 | M48343 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 3.31e-03 | 62 | 68 | 3 | M11521 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 3.57e-03 | 130 | 68 | 4 | MM15455 | |
| Pathway | KEGG_RETINOL_METABOLISM | 3.62e-03 | 64 | 68 | 3 | M9488 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 3.77e-03 | 132 | 68 | 4 | M724 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.30e-03 | 68 | 68 | 3 | M27303 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 4.48e-03 | 69 | 68 | 3 | M16894 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.64e-03 | 140 | 68 | 4 | M587 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.67e-03 | 70 | 68 | 3 | M16794 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 4.98e-03 | 22 | 68 | 2 | M26929 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 4.98e-03 | 22 | 68 | 2 | M27445 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 5.05e-03 | 72 | 68 | 3 | M9257 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 5.11e-03 | 439 | 68 | 7 | M42563 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 5.43e-03 | 23 | 68 | 2 | M14766 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 5.43e-03 | 23 | 68 | 2 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 5.43e-03 | 23 | 68 | 2 | M18719 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 5.43e-03 | 23 | 68 | 2 | MM14557 | |
| Pubmed | THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP4 NPNT | 1.27e-16 | 167 | 81 | 13 | 22159717 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | VEGFC THBS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LTBP1 FST LTBP4 PROS1 NPNT | 7.25e-16 | 248 | 81 | 14 | 24006456 |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.30e-13 | 79 | 81 | 9 | 18757743 | |
| Pubmed | 4.27e-13 | 29 | 81 | 7 | 22613833 | ||
| Pubmed | 1.11e-11 | 175 | 81 | 10 | 28071719 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.14e-11 | 135 | 81 | 9 | 28675934 | |
| Pubmed | 6.37e-11 | 146 | 81 | 9 | 27068509 | ||
| Pubmed | 9.69e-11 | 153 | 81 | 9 | 25037231 | ||
| Pubmed | 3.36e-10 | 71 | 81 | 7 | 33541421 | ||
| Pubmed | 4.08e-10 | 6 | 81 | 4 | 19349279 | ||
| Pubmed | 5.06e-10 | 18 | 81 | 5 | 14730302 | ||
| Pubmed | 5.06e-10 | 18 | 81 | 5 | 11311202 | ||
| Pubmed | 1.30e-09 | 205 | 81 | 9 | 20436479 | ||
| Pubmed | 1.90e-09 | 8 | 81 | 4 | 8872465 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PLXNA3 CACNA2D1 ERBB2 THBS1 FRAS1 FBLN5 FBN1 PXDN CELSR2 LAMA1 LRP1 LAMC1 LTBP1 LTBP3 NOTCH1 PROS1 SORL1 | 2.02e-09 | 1201 | 81 | 17 | 35696571 |
| Pubmed | 5.67e-09 | 10 | 81 | 4 | 11784026 | ||
| Pubmed | 5.67e-09 | 10 | 81 | 4 | 9034910 | ||
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 8.90e-09 | 11 | 81 | 4 | 23472759 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 8.90e-09 | 11 | 81 | 4 | 21524702 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 11960985 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 2474823 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 1.22e-08 | 3 | 81 | 3 | 23772048 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 1.22e-08 | 3 | 81 | 3 | 24787690 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 3011597 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 6756216 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 37806378 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 7840644 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 1.22e-08 | 3 | 81 | 3 | 15670660 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 8018987 | ||
| Pubmed | Expression of laminin chains during myogenic differentiation. | 1.22e-08 | 3 | 81 | 3 | 7510707 | |
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 1.22e-08 | 3 | 81 | 3 | 33586683 | |
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 1.22e-08 | 3 | 81 | 3 | 3157987 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 2169444 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 1.22e-08 | 3 | 81 | 3 | 8486690 | |
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 1.22e-08 | 3 | 81 | 3 | 16801720 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 1.22e-08 | 3 | 81 | 3 | 10424757 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 2347582 | ||
| Pubmed | A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance. | 1.22e-08 | 3 | 81 | 3 | 33420373 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 1.22e-08 | 3 | 81 | 3 | 7748347 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 3006456 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 1.22e-08 | 3 | 81 | 3 | 9145544 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 1.22e-08 | 3 | 81 | 3 | 6816803 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 1.22e-08 | 3 | 81 | 3 | 15554233 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 35354963 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 6370228 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 2935875 | ||
| Pubmed | 1.22e-08 | 118 | 81 | 7 | 21078624 | ||
| Pubmed | 1.33e-08 | 12 | 81 | 4 | 9396756 | ||
| Pubmed | 2.68e-08 | 14 | 81 | 4 | 36347239 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 3.65e-08 | 15 | 81 | 4 | 12921739 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.65e-08 | 15 | 81 | 4 | 15895400 | |
| Pubmed | 3.65e-08 | 15 | 81 | 4 | 9264260 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 15611103 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 8813054 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 12631290 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 2893758 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 4.86e-08 | 4 | 81 | 3 | 11104663 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 12429738 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 11893554 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 29663519 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 12851412 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 9733106 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 36224745 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 9202249 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 19618839 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 4.86e-08 | 4 | 81 | 3 | 3996732 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 9241435 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 10880953 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 9002638 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 15193143 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 16157329 | ||
| Pubmed | 4.86e-08 | 16 | 81 | 4 | 17601529 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 8.15e-08 | 18 | 81 | 4 | 39040056 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 11969289 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 19897194 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 11836246 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 8621625 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 1316195 | ||
| Pubmed | Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. | 1.21e-07 | 5 | 81 | 3 | 8719886 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 7738026 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 8892527 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 7026729 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 1.21e-07 | 5 | 81 | 3 | 19193628 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 9719032 | ||
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 1.21e-07 | 5 | 81 | 3 | 22079585 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 10358022 | ||
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 1.21e-07 | 5 | 81 | 3 | 8613743 | |
| Pubmed | 1.29e-07 | 20 | 81 | 4 | 22911573 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.40e-07 | 101 | 81 | 6 | 20551380 | |
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 1678389 | ||
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 17257171 | ||
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 26807981 | ||
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 12027900 | ||
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 2.42e-07 | 6 | 81 | 3 | 3794389 | |
| Interaction | NTN5 interactions | 3.89e-12 | 24 | 80 | 7 | int:NTN5 | |
| Interaction | IGFL3 interactions | 5.86e-10 | 75 | 80 | 8 | int:IGFL3 | |
| Interaction | PRG2 interactions | THBS1 FRAS1 PXDN CELSR2 PRF1 LAMC1 LAMC2 LTBP3 LTBP4 NOTCH1 PROS1 SORL1 | 1.30e-09 | 285 | 80 | 12 | int:PRG2 |
| Interaction | SIRPD interactions | 1.78e-09 | 86 | 80 | 8 | int:SIRPD | |
| Interaction | ZFP41 interactions | 2.68e-09 | 57 | 80 | 7 | int:ZFP41 | |
| Interaction | HOXA1 interactions | TRAF1 FBLN5 FBN1 VWF LTBP1 LTBP3 FST LTBP4 KRT38 KRT37 NOTCH1 | 1.58e-07 | 356 | 80 | 11 | int:HOXA1 |
| Interaction | LYZL1 interactions | 4.40e-07 | 118 | 80 | 7 | int:LYZL1 | |
| Interaction | ZDHHC15 interactions | 6.51e-07 | 125 | 80 | 7 | int:ZDHHC15 | |
| Interaction | FBXO2 interactions | PLXNA3 CACNA2D1 FRAS1 FBN1 PXDN LAMA1 LAMC1 LAMC2 LTBP4 NOTCH1 SORL1 | 6.59e-07 | 411 | 80 | 11 | int:FBXO2 |
| Interaction | CFC1 interactions | 6.87e-07 | 126 | 80 | 7 | int:CFC1 | |
| Interaction | SORL1 interactions | 1.27e-06 | 138 | 80 | 7 | int:SORL1 | |
| Interaction | SLURP1 interactions | 1.69e-06 | 144 | 80 | 7 | int:SLURP1 | |
| Interaction | ZNF408 interactions | 1.77e-06 | 145 | 80 | 7 | int:ZNF408 | |
| Interaction | TGFB1 interactions | 4.58e-06 | 317 | 80 | 9 | int:TGFB1 | |
| Interaction | CACNA1A interactions | 9.50e-06 | 123 | 80 | 6 | int:CACNA1A | |
| Interaction | ZNF74 interactions | 9.75e-06 | 34 | 80 | 4 | int:ZNF74 | |
| Interaction | VEGFD interactions | 1.53e-05 | 38 | 80 | 4 | int:VEGFD | |
| Interaction | ADH1B interactions | 1.67e-05 | 13 | 80 | 3 | int:ADH1B | |
| Interaction | FBXO6 interactions | FRAS1 PXDN CELSR2 MTHFD1 PRF1 LRP1 LAMC1 LTBP1 LTBP3 LTBP4 PROS1 SORL1 | 2.46e-05 | 717 | 80 | 12 | int:FBXO6 |
| Interaction | C1orf54 interactions | 5.36e-05 | 167 | 80 | 6 | int:C1orf54 | |
| Interaction | CCN6 interactions | 5.58e-05 | 19 | 80 | 3 | int:CCN6 | |
| Interaction | NELL2 interactions | 5.81e-05 | 53 | 80 | 4 | int:NELL2 | |
| Interaction | VAV3 interactions | 6.73e-05 | 55 | 80 | 4 | int:VAV3 | |
| Interaction | LAMA2 interactions | 1.01e-04 | 23 | 80 | 3 | int:LAMA2 | |
| Interaction | HRG interactions | 1.15e-04 | 63 | 80 | 4 | int:HRG | |
| Interaction | SLA2 interactions | 1.15e-04 | 24 | 80 | 3 | int:SLA2 | |
| Interaction | FBN2 interactions | 1.30e-04 | 65 | 80 | 4 | int:FBN2 | |
| Interaction | COL7A1 interactions | 1.30e-04 | 25 | 80 | 3 | int:COL7A1 | |
| Interaction | F8 interactions | 1.30e-04 | 25 | 80 | 3 | int:F8 | |
| Interaction | IL5RA interactions | 1.35e-04 | 124 | 80 | 5 | int:IL5RA | |
| Interaction | FBLN2 interactions | 1.38e-04 | 66 | 80 | 4 | int:FBLN2 | |
| Interaction | LAMA1 interactions | 1.38e-04 | 66 | 80 | 4 | int:LAMA1 | |
| Interaction | ADH1A interactions | 1.54e-04 | 5 | 80 | 2 | int:ADH1A | |
| Interaction | ARRDC1 interactions | 1.55e-04 | 68 | 80 | 4 | int:ARRDC1 | |
| Interaction | LY86 interactions | 2.25e-04 | 217 | 80 | 6 | int:LY86 | |
| Interaction | ZNF707 interactions | 2.76e-04 | 79 | 80 | 4 | int:ZNF707 | |
| Interaction | SDF2L1 interactions | 2.92e-04 | 322 | 80 | 7 | int:SDF2L1 | |
| Interaction | PIK3R2 interactions | 3.08e-04 | 230 | 80 | 6 | int:PIK3R2 | |
| Interaction | DYRK1A interactions | 3.35e-04 | 552 | 80 | 9 | int:DYRK1A | |
| Interaction | H2BC9 interactions | 3.89e-04 | 446 | 80 | 8 | int:H2BC9 | |
| Interaction | B3GLCT interactions | 3.91e-04 | 36 | 80 | 3 | int:B3GLCT | |
| Interaction | FBLN5 interactions | 4.28e-04 | 159 | 80 | 5 | int:FBLN5 | |
| Cytoband | 4q23 | 5.90e-06 | 20 | 81 | 3 | 4q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 3.94e-05 | 37 | 81 | 3 | chr4q23 | |
| Cytoband | 17q12-q21 | 1.47e-03 | 32 | 81 | 2 | 17q12-q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.53e-03 | 473 | 81 | 5 | chr17q21 | |
| GeneFamily | Laminin subunits | 3.40e-10 | 12 | 63 | 5 | 626 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.61e-07 | 4 | 63 | 3 | 628 | |
| GeneFamily | Alcohol dehydrogenases | 2.23e-06 | 8 | 63 | 3 | 397 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 7.14e-05 | 4 | 63 | 2 | 1096 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.23e-04 | 34 | 63 | 3 | 487 | |
| GeneFamily | Keratins, type I | 4.26e-03 | 28 | 63 | 2 | 608 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 4.57e-03 | 29 | 63 | 2 | 782 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 NPNT | 3.93e-17 | 196 | 81 | 15 | M3008 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 NPNT | 8.75e-16 | 191 | 81 | 14 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | LAMB4 THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 NPNT | 6.15e-15 | 275 | 81 | 15 | M5884 |
| Coexpression | NABA_MATRISOME | VEGFC PLXNA3 LAMB4 THBS1 FRAS1 FBLN5 FBN1 VWF PXDN ADAM18 LAMA1 WIF1 MUC19 LAMA2 ADAMTS18 LAMC1 LAMC2 LTBP1 LTBP3 FST LTBP4 EGFL6 NPNT | 3.68e-14 | 1026 | 81 | 23 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | THBS1 FRAS1 FBLN5 FBN1 VWF PXDN LAMA1 LAMA2 LAMC1 LAMC2 LTBP1 LTBP3 LTBP4 NPNT | 1.06e-13 | 270 | 81 | 14 | MM17057 |
| Coexpression | NABA_MATRISOME | VEGFC PLXNA3 THBS1 FRAS1 FBLN5 FBN1 VWF PXDN ADAM18 LAMA1 WIF1 MUC19 LAMA2 ADAMTS18 LAMC1 LAMC2 LTBP1 LTBP3 FST LTBP4 EGFL6 NPNT | 2.54e-13 | 1008 | 81 | 22 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.55e-09 | 40 | 81 | 6 | M5887 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.19e-08 | 200 | 81 | 9 | M5930 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.17e-07 | 261 | 81 | 9 | M1834 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | THBS1 ENPP2 ZNF423 LAMA1 WIF1 LRP1 LAMC1 FST CBLB LTBP4 PROS1 | 2.60e-07 | 479 | 81 | 11 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | THBS1 ENPP2 ZNF423 LAMA1 WIF1 LRP1 LAMC1 FST CBLB LTBP4 PROS1 | 2.82e-07 | 483 | 81 | 11 | MM1082 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 7.17e-07 | 23 | 81 | 4 | M48001 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.39e-06 | 194 | 81 | 7 | M39122 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 2.92e-06 | 200 | 81 | 7 | M3584 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.98e-06 | 385 | 81 | 9 | M39264 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 3.56e-06 | 505 | 81 | 10 | M39167 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SP8 ERBB2 ERBB3 LAMA1 WIF1 ADAMTS18 LAMC2 SHISA2 FST TACSTD2 NOTCH1 PROS1 NPNT TMEM63A | 4.86e-06 | 1074 | 81 | 14 | M1941 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 9.40e-06 | 444 | 81 | 9 | MM1051 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 1.21e-05 | 164 | 81 | 6 | M41676 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | CACNA2D1 THBS1 TRAF1 VWF PXDN CD27 LAMA2 LAMC1 LTBP1 LTBP3 SORL1 | 1.33e-05 | 721 | 81 | 11 | M1999 |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 1.89e-05 | 485 | 81 | 9 | M8513 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 1.98e-05 | 179 | 81 | 6 | M41745 | |
| Coexpression | MCDOWELL_ACUTE_LUNG_INJURY_DN | 2.05e-05 | 52 | 81 | 4 | MM693 | |
| Coexpression | NOTCH_DN.V1_DN | 2.24e-05 | 183 | 81 | 6 | M2788 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | VEGFC CACNA2D1 FBN1 ENPP2 ZNF423 LAMC1 LRRC4C FST NPNT ADH1B ADH1C | 2.36e-05 | 767 | 81 | 11 | M39209 |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP | 2.61e-05 | 188 | 81 | 6 | M5648 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 2.93e-05 | 115 | 81 | 5 | M45752 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 3.12e-05 | 20 | 81 | 3 | MM17053 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.18e-05 | 117 | 81 | 5 | M39300 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 3.38e-05 | 59 | 81 | 4 | M47993 | |
| Coexpression | LEE_BMP2_TARGETS_UP | FBLN5 VWF ENPP2 LRP1 LAMA2 LTBP1 LTBP4 NPNT ADH1A ADH1B ADH1C | 3.67e-05 | 805 | 81 | 11 | MM1067 |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP | 3.69e-05 | 200 | 81 | 6 | M8212 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 3.69e-05 | 200 | 81 | 6 | M7457 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN | 3.69e-05 | 200 | 81 | 6 | M7453 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN | 3.69e-05 | 200 | 81 | 6 | M4354 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 3.72e-05 | 296 | 81 | 7 | M41675 | |
| Coexpression | JEON_SMAD6_TARGETS_UP | 5.49e-05 | 24 | 81 | 3 | M4592 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_0HR | 6.28e-05 | 69 | 81 | 4 | MM1024 | |
| Coexpression | HALLMARK_COAGULATION | 6.99e-05 | 138 | 81 | 5 | M5946 | |
| Coexpression | RELA_DN.V1_DN | 7.23e-05 | 139 | 81 | 5 | M2695 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL | 7.42e-05 | 72 | 81 | 4 | M45791 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | 9.33e-05 | 740 | 81 | 10 | M41202 | |
| Coexpression | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP | 1.29e-04 | 83 | 81 | 4 | M10660 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 1.35e-04 | 84 | 81 | 4 | M15484 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PLXNA3 CACNA2D1 LYPD6 PXDN ENPP2 HECTD4 LTBP1 LRRC4C NOTCH1 PROS1 SORL1 TMEM63A | 1.40e-04 | 1102 | 81 | 12 | M2369 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.40e-04 | 6 | 81 | 2 | M48000 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 1.41e-04 | 630 | 81 | 9 | MM1038 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 1.42e-04 | 85 | 81 | 4 | M45761 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 1.59e-04 | 34 | 81 | 3 | M14043 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PLXNA3 CACNA2D1 LYPD6 PXDN ENPP2 HECTD4 LTBP1 LRRC4C NOTCH1 PROS1 SORL1 TMEM63A | 1.68e-04 | 1124 | 81 | 12 | MM1070 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.73e-04 | 35 | 81 | 3 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.73e-04 | 35 | 81 | 3 | M11788 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 1.81e-04 | 267 | 81 | 6 | MM984 | |
| Coexpression | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP | 1.84e-04 | 91 | 81 | 4 | MM622 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.84e-04 | 91 | 81 | 4 | M40180 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.85e-04 | 268 | 81 | 6 | M45796 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.89e-04 | 36 | 81 | 3 | MM1212 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP | 2.13e-04 | 175 | 81 | 5 | M6684 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 2.30e-04 | 178 | 81 | 5 | M17079 | |
| Coexpression | ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR | 2.45e-04 | 98 | 81 | 4 | M39210 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_UP | 2.59e-04 | 40 | 81 | 3 | M3649 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 2.62e-04 | 286 | 81 | 6 | M45746 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 2.86e-04 | 546 | 81 | 8 | M3837 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 2.90e-04 | 694 | 81 | 9 | MM1039 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP | 3.19e-04 | 191 | 81 | 5 | M9517 | |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 3.19e-04 | 191 | 81 | 5 | M2647 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 3.33e-04 | 422 | 81 | 7 | M7396 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 3.50e-04 | 302 | 81 | 6 | MM16604 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 3.59e-04 | 196 | 81 | 5 | M9867 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP | 3.68e-04 | 197 | 81 | 5 | M4504 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN | 3.76e-04 | 198 | 81 | 5 | M8152 | |
| Coexpression | GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP | 3.76e-04 | 198 | 81 | 5 | M7702 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 3.76e-04 | 198 | 81 | 5 | M7610 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP | 3.76e-04 | 198 | 81 | 5 | M4478 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN | 3.85e-04 | 199 | 81 | 5 | M7659 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 3.85e-04 | 199 | 81 | 5 | M7319 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP | 3.85e-04 | 199 | 81 | 5 | M3641 | |
| Coexpression | GSE11924_TH1_VS_TH2_CD4_TCELL_DN | 3.85e-04 | 199 | 81 | 5 | M3160 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_UP | 3.94e-04 | 200 | 81 | 5 | M9406 | |
| Coexpression | GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN | 3.94e-04 | 200 | 81 | 5 | M9665 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP | 3.94e-04 | 200 | 81 | 5 | M9658 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP | 3.94e-04 | 200 | 81 | 5 | M6038 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 3.94e-04 | 111 | 81 | 4 | MM705 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 4.02e-04 | 310 | 81 | 6 | MM16608 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 4.41e-04 | 205 | 81 | 5 | M39302 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | 4.62e-04 | 587 | 81 | 8 | M17572 | |
| Coexpression | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER | 5.63e-04 | 52 | 81 | 3 | M19766 | |
| Coexpression | PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP | 6.10e-04 | 12 | 81 | 2 | M2421 | |
| Coexpression | PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP | 6.10e-04 | 12 | 81 | 2 | MM939 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_2 | 6.18e-04 | 125 | 81 | 4 | M5888 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 6.24e-04 | 337 | 81 | 6 | M13206 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_UP | 6.29e-04 | 54 | 81 | 3 | M6977 | |
| Coexpression | AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP | 6.36e-04 | 126 | 81 | 4 | M2309 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_2 | 6.56e-04 | 127 | 81 | 4 | MM1113 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 6.64e-04 | 55 | 81 | 3 | MM3666 | |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 6.64e-04 | 55 | 81 | 3 | MM397 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 6.73e-04 | 780 | 81 | 9 | M2324 | |
| Coexpression | DESCARTES_ORGANOGENESIS_MYOCYTES | 6.95e-04 | 129 | 81 | 4 | MM3644 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | 7.11e-04 | 786 | 81 | 9 | M10961 | |
| Coexpression | TRAVAGLINI_LUNG_ARTERY_CELL | 7.36e-04 | 131 | 81 | 4 | M41662 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | VEGFC THBS1 FBLN5 FBN1 PXDN ENPP2 LRP1 LAMA2 LAMC1 LTBP1 LTBP3 LTBP4 PROS1 ADH1C | 1.68e-09 | 466 | 79 | 14 | GSM777050_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.83e-09 | 97 | 79 | 8 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | THBS1 FBLN5 FBN1 PXDN ENPP2 LRP1 LAMA2 LAMC1 LTBP1 FST LTBP4 PROS1 ADH1C | 7.65e-09 | 437 | 79 | 13 | GSM777046_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | CACNA2D1 THBS1 FBLN5 FBN1 PXDN ENPP2 LRP1 LAMA2 LAMC1 FST LTBP4 PROS1 ADH1C | 1.17e-08 | 453 | 79 | 13 | GSM777067_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | CACNA2D1 THBS1 FBN1 PXDN ENPP2 LRP1 LAMA2 LAMC1 LTBP1 LTBP4 PROS1 ADH1C | 8.91e-08 | 445 | 79 | 12 | GSM777043_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | VEGFC PLBD1 THBS1 FRAS1 FBLN5 FBN1 LRP1 LAMA2 LTBP3 FST LTBP4 PROS1 NPNT TMEM63A ADH1C | 1.53e-07 | 778 | 79 | 15 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 2.87e-07 | 175 | 79 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | THBS1 FBLN5 FBN1 PXDN ENPP2 LAMC1 LAMC2 LTBP1 LTBP4 PROS1 STAB1 | 6.65e-07 | 439 | 79 | 11 | GSM777059_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 8.69e-07 | 87 | 79 | 6 | GSM777050_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | VEGFC THBS1 FBLN5 FBN1 PXDN ENPP2 LRP1 LAMC1 LTBP4 PROS1 ADH1C | 9.44e-07 | 455 | 79 | 11 | GSM777055_500 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.10e-06 | 369 | 79 | 10 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 1.19e-06 | 372 | 79 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.65e-06 | 97 | 79 | 6 | GSM777046_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | CACNA2D1 FRAS1 CELSR2 ENPP2 LAMA1 LAMC1 LAMC2 LTBP1 NOTCH1 EGFL6 | 2.18e-06 | 398 | 79 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 3.44e-06 | 62 | 79 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | CACNA2D1 FRAS1 FBN1 CELSR2 ENPP2 LAMA1 MKRN2OS LAMC1 LAMC2 LTBP1 NOTCH1 EGFL6 NPNT | 5.88e-06 | 783 | 79 | 13 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 6.46e-06 | 450 | 79 | 10 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 7.68e-06 | 459 | 79 | 10 | GSM777037_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CACNA2D1 LYPD6 FRAS1 FBN1 PNLIPRP1 LAMA1 LRP1 ADAMTS18 LTBP1 LRRC4C FST EGFL6 ADH1C | 1.11e-05 | 831 | 79 | 13 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | SP8 CACNA2D1 THBS1 FRAS1 ERBB3 FBLN5 VWF CELSR2 WIF1 SHISA2 LTBP3 LTBP4 EGFL6 NPNT | 1.26e-05 | 973 | 79 | 14 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 1.37e-05 | 82 | 79 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | RNF14 CACNA2D1 LYPD6 TRAF1 ADAMTS18 SHISA2 LTBP3 TACSTD2 EGFL6 | 1.38e-05 | 388 | 79 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.75e-05 | 146 | 79 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 2.05e-05 | 408 | 79 | 9 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 2.27e-05 | 91 | 79 | 5 | GSM777059_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 2.55e-05 | 156 | 79 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.72e-05 | 423 | 79 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | CACNA2D1 THBS1 FBLN5 FBN1 ENPP2 LAMA1 LAMC1 LAMC2 LTBP1 TACSTD2 NPNT SORL1 ADH1C | 2.73e-05 | 905 | 79 | 13 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | CACNA2D1 LYPD6 THBS1 ERBB3 CELSR2 LAMC1 LAMC2 EZH1 CBLB TACSTD2 NPNT SORL1 | 2.75e-05 | 774 | 79 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 2.94e-05 | 96 | 79 | 5 | GSM777063_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 3.13e-05 | 240 | 79 | 7 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | VEGFC RNF14 CACNA2D1 LYPD6 TRAF1 FBN1 ZNF423 ADAMTS18 SHISA2 LTBP3 TACSTD2 EGFL6 | 3.40e-05 | 791 | 79 | 12 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 3.50e-05 | 165 | 79 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.55e-05 | 336 | 79 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 4.88e-05 | 456 | 79 | 9 | GSM777032_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.14e-05 | 354 | 79 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | CACNA2D1 LYPD6 THBS1 FRAS1 FBLN5 VWF WIF1 LTBP1 LTBP3 LRRC4C LTBP4 EGFL6 NPNT | 5.41e-05 | 967 | 79 | 13 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | CACNA2D1 LYPD6 THBS1 FBLN5 VWF CD27 WIF1 SHISA2 LTBP1 LTBP3 LTBP4 EGFL6 NPNT | 5.41e-05 | 967 | 79 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 5.45e-05 | 357 | 79 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | CACNA2D1 LYPD6 THBS1 FRAS1 FBLN5 VWF WIF1 SHISA2 LTBP1 LTBP3 LTBP4 EGFL6 NPNT | 5.70e-05 | 972 | 79 | 13 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | CACNA2D1 THBS1 FBLN5 FBN1 CELSR2 WIF1 HECTD4 LAMA2 LTBP3 LRRC4C LTBP4 EGFL6 TMEM63A | 5.76e-05 | 973 | 79 | 13 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | SP8 CACNA2D1 LYPD6 THBS1 FBLN5 VWF CELSR2 WIF1 SHISA2 LTBP3 LTBP4 EGFL6 NPNT | 5.95e-05 | 976 | 79 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 6.04e-05 | 182 | 79 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SP8 CACNA2D1 THBS1 ERBB3 FBLN5 VWF CELSR2 INSM1 WIF1 LTBP3 LTBP4 EGFL6 NPNT | 6.46e-05 | 984 | 79 | 13 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_500 | 6.91e-05 | 59 | 79 | 4 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.89e-05 | 191 | 79 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_500 | 7.90e-05 | 118 | 79 | 5 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 8.34e-05 | 489 | 79 | 9 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | CACNA2D1 LYPD6 FBN1 ENPP2 LAMA1 LRP1 LTBP1 LRRC4C FST LTBP4 EGFL6 | 8.93e-05 | 740 | 79 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 9.22e-05 | 385 | 79 | 8 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.62e-05 | 123 | 79 | 5 | gudmap_developingKidney_e15.5_S-shaped body_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 9.73e-05 | 388 | 79 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.23e-04 | 207 | 79 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.25e-04 | 130 | 79 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | 1.28e-04 | 69 | 79 | 4 | GSM605872_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | CACNA2D1 FBLN5 FBN1 PXDN ZNF423 LAMA1 LRP1 LAMA2 LTBP4 PROS1 ADH1C | 1.31e-04 | 773 | 79 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | Myeloid Cells, GN.BM, CD11b+ Ly6-G+, Bone marrow, avg-4 | 1.35e-04 | 70 | 79 | 4 | GSM605846_100 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_500 | 1.36e-04 | 27 | 79 | 3 | gudmap_kidney_adult_CortVasc_Tie2_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CACNA2D1 THBS1 FRAS1 FBN1 ZNF423 LAMA1 LRP1 LAMA2 LRRC4C LTBP4 ADH1C | 1.37e-04 | 777 | 79 | 11 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | SP8 LYPD6 FRAS1 ERBB3 PNLIPRP1 ADAMTS18 LAMC2 TACSTD2 NSD3 NPNT SORL1 | 1.42e-04 | 780 | 79 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | Myeloid Cells, GN.Arth.BM, CD11b+ Ly6-G+, Bone marrow, avg-3 | 1.43e-04 | 71 | 79 | 4 | GSM854303_100 | |
| CoexpressionAtlas | BM Top 100 - lung | 1.51e-04 | 72 | 79 | 4 | BM Top 100 - lung | |
| CoexpressionAtlas | Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2 | 1.51e-04 | 72 | 79 | 4 | GSM854320_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.59e-04 | 73 | 79 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.62e-04 | 418 | 79 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | CACNA2D1 THBS1 TRAF1 CELSR2 ABCA13 ENPP2 LAMA1 LAMC1 EZH1 CBLB SORL1 | 1.68e-04 | 795 | 79 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_200 | 1.86e-04 | 76 | 79 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_k1_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 1.95e-04 | 77 | 79 | 4 | GSM854294_100 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.06e-04 | 433 | 79 | 8 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | VEGFC SP8 CACNA2D1 THBS1 PNLIPRP1 ZNF423 INSM1 LAMC1 LTBP1 TACSTD2 SORL1 | 2.15e-04 | 818 | 79 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.15e-04 | 146 | 79 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | CACNA2D1 LYPD6 THBS1 FBLN5 VWF WIF1 LTBP1 LTBP3 LRRC4C LTBP4 EGFL6 NPNT | 2.28e-04 | 967 | 79 | 12 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | VEGFC CACNA2D1 THBS1 FBLN5 FBN1 LAMA1 LRP1 ADAMTS18 LAMC1 FST ADH1B ADH1C | 2.46e-04 | 975 | 79 | 12 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 2.73e-04 | 34 | 79 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_100 | 2.86e-04 | 85 | 79 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | PLBD1 LYPD6 THBS1 FBN1 PNLIPRP1 LAMA1 LRP1 NFXL1 LTBP1 LRRC4C ADH1C | 2.95e-04 | 849 | 79 | 11 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | CACNA2D1 THBS1 FBLN5 FBN1 VWF CSF3R ENPP2 LAMA2 ADAMTS18 LTBP3 LTBP4 EGFL6 SORL1 | 2.98e-04 | 1148 | 79 | 13 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | SP8 THBS1 ERBB3 ENPP2 WIF1 LTBP1 FST TACSTD2 EGFL6 NPNT SORL1 | 2.98e-04 | 850 | 79 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 2.99e-04 | 86 | 79 | 4 | GSM605850_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_100 | 3.12e-04 | 87 | 79 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100 | |
| CoexpressionAtlas | placenta | 3.21e-04 | 349 | 79 | 7 | placenta | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | PLBD1 LYPD6 THBS1 FBN1 PNLIPRP1 LAMA1 LRP1 NFXL1 LTBP1 LRRC4C FST | 3.23e-04 | 858 | 79 | 11 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_500 | 3.52e-04 | 37 | 79 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 3.61e-04 | 356 | 79 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 3.78e-04 | 165 | 79 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 3.93e-04 | 361 | 79 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_200 | 4.10e-04 | 168 | 79 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 4.11e-04 | 39 | 79 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k1_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4 | 4.13e-04 | 364 | 79 | 7 | GSM854276_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.17e-04 | 607 | 79 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 4.20e-04 | 94 | 79 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.27e-04 | 261 | 79 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103- F480+, Small Intestine, avg-4 | 4.41e-04 | 368 | 79 | 7 | GSM854258_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 4.43e-04 | 40 | 79 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.63e-04 | 265 | 79 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 4.78e-04 | 373 | 79 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.SI, CD45+ MHCII+ CD11c-lo CD11b+, Small Intestine, avg-5 | 5.09e-04 | 377 | 79 | 7 | GSM854280_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 5.18e-04 | 497 | 79 | 8 | PCBC_ECTO_fibroblast_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_100 | 5.31e-04 | 100 | 79 | 4 | PCBC_EB_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103- F4/80+, Small Intestine, avg-7 | 5.42e-04 | 381 | 79 | 7 | GSM854262_500 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.59e-11 | 185 | 81 | 9 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.15e-11 | 187 | 81 | 9 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.45e-11 | 188 | 81 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.09e-11 | 190 | 81 | 9 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.78e-11 | 192 | 81 | 9 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.78e-11 | 192 | 81 | 9 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.78e-11 | 192 | 81 | 9 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.78e-11 | 192 | 81 | 9 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.15e-11 | 193 | 81 | 9 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.15e-11 | 193 | 81 | 9 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.54e-11 | 194 | 81 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.35e-11 | 196 | 81 | 9 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-11 | 196 | 81 | 9 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-11 | 196 | 81 | 9 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-10 | 198 | 81 | 9 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.12e-10 | 200 | 81 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-10 | 200 | 81 | 9 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-10 | 200 | 81 | 9 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-10 | 200 | 81 | 9 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-10 | 200 | 81 | 9 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-10 | 200 | 81 | 9 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-10 | 200 | 81 | 9 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-10 | 170 | 81 | 8 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-10 | 170 | 81 | 8 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-10 | 170 | 81 | 8 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-09 | 181 | 81 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-09 | 189 | 81 | 8 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.07e-09 | 189 | 81 | 8 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-09 | 190 | 81 | 8 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-09 | 190 | 81 | 8 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-09 | 191 | 81 | 8 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-09 | 191 | 81 | 8 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-09 | 191 | 81 | 8 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-09 | 191 | 81 | 8 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.25e-09 | 191 | 81 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-09 | 192 | 81 | 8 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-09 | 192 | 81 | 8 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-09 | 192 | 81 | 8 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.34e-09 | 192 | 81 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-09 | 192 | 81 | 8 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-09 | 193 | 81 | 8 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-09 | 193 | 81 | 8 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-09 | 193 | 81 | 8 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-09 | 193 | 81 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-09 | 193 | 81 | 8 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-09 | 193 | 81 | 8 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-09 | 193 | 81 | 8 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-09 | 194 | 81 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.54e-09 | 194 | 81 | 8 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-09 | 194 | 81 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 2.54e-09 | 194 | 81 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-09 | 195 | 81 | 8 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-09 | 195 | 81 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.65e-09 | 195 | 81 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.65e-09 | 195 | 81 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-09 | 195 | 81 | 8 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-09 | 195 | 81 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-09 | 195 | 81 | 8 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-09 | 196 | 81 | 8 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 2.75e-09 | 196 | 81 | 8 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-09 | 196 | 81 | 8 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-09 | 197 | 81 | 8 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-09 | 197 | 81 | 8 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-09 | 197 | 81 | 8 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-09 | 197 | 81 | 8 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-09 | 197 | 81 | 8 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-09 | 197 | 81 | 8 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 2.98e-09 | 198 | 81 | 8 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.98e-09 | 198 | 81 | 8 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.98e-09 | 198 | 81 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 2.98e-09 | 198 | 81 | 8 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.98e-09 | 198 | 81 | 8 | 08d393853e195a7eacace454153e425a273e2d23 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.10e-09 | 199 | 81 | 8 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.10e-09 | 199 | 81 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.23e-09 | 200 | 81 | 8 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-09 | 200 | 81 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.23e-09 | 200 | 81 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-09 | 200 | 81 | 8 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-09 | 200 | 81 | 8 | f74b9b0e27afedd589e828d30194e8417029817a | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-09 | 200 | 81 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.23e-09 | 200 | 81 | 8 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-09 | 200 | 81 | 8 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 3.23e-09 | 200 | 81 | 8 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-09 | 200 | 81 | 8 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-09 | 200 | 81 | 8 | f6cf98aad53aa8b3fa02cf874d6f7cd75530a213 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-intermediate_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.23e-09 | 200 | 81 | 8 | 6461d25fd8fb52921b188f083fbe808535d3130b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-09 | 200 | 81 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-09 | 200 | 81 | 8 | 5fdca7959134a5c8e06e5d6d14aafe34b963aef2 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 2.56e-08 | 169 | 81 | 7 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-08 | 176 | 81 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-08 | 176 | 81 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 3.81e-08 | 179 | 81 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-08 | 180 | 81 | 7 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.11e-08 | 181 | 81 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-08 | 182 | 81 | 7 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-08 | 182 | 81 | 7 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-08 | 182 | 81 | 7 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-08 | 182 | 81 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-08 | 184 | 81 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-08 | 185 | 81 | 7 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| Computational | Immune / stress response genes. | CACNA2D1 ERBB2 THBS1 VWF CD27 ENPP2 LRP1 LTBP1 ATF2 ADH1A STAB1 | 4.30e-06 | 383 | 57 | 11 | MODULE_33 |
| Computational | Metal / Ca ion binding. | 6.93e-05 | 133 | 57 | 6 | MODULE_324 | |
| Computational | Lung genes. | 8.15e-05 | 434 | 57 | 10 | MODULE_5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.36e-04 | 50 | 57 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING | |
| Computational | Placenta genes. | ERBB2 ERBB3 VWF CSF3R ENPP2 LRP1 LTBP1 TACSTD2 TMEM63A STAB1 | 1.39e-04 | 463 | 57 | 10 | MODULE_38 |
| Computational | DRG (dorsal root ganglia) genes. | 1.70e-04 | 384 | 57 | 9 | MODULE_2 | |
| Computational | Oxidoreductases. | 2.03e-04 | 22 | 57 | 3 | MODULE_373 | |
| Computational | Neighborhood of IGFBP1 | 2.28e-04 | 57 | 57 | 4 | CAR_IGFBP1 | |
| Computational | Neighborhood of CDH11 | 2.99e-04 | 25 | 57 | 3 | GNF2_CDH11 | |
| Computational | Liver genes - metabolism and xenobiotics. | 6.66e-04 | 563 | 57 | 10 | MODULE_23 | |
| Computational | Adhesion molecules. | 8.76e-04 | 141 | 57 | 5 | MODULE_122 | |
| Computational | Neighborhood of PTX3 | 8.92e-04 | 36 | 57 | 3 | GNF2_PTX3 | |
| Computational | Genes in the cancer module 55. | ERBB3 CSF3R PRF1 ENPP2 LRP1 C6 FST TACSTD2 ADH1A ADH1B STAB1 ADH1C | 1.17e-03 | 832 | 57 | 12 | MODULE_55 |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | ERBB3 VWF CSF3R PRF1 ENPP2 C6 FST TACSTD2 ADH1A ADH1B STAB1 ADH1C | 1.21e-03 | 835 | 57 | 12 | MODULE_88 |
| Computational | Genes in the cancer module 514. | 1.21e-03 | 10 | 57 | 2 | MODULE_514 | |
| Computational | Trachea genes. | 1.45e-03 | 415 | 57 | 8 | MODULE_6 | |
| Computational | Genes in the cancer module 121. | 1.84e-03 | 99 | 57 | 4 | MODULE_121 | |
| Computational | Genes in the cancer module 399. | 2.60e-03 | 52 | 57 | 3 | MODULE_399 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.37e-11 | 83 | 80 | 9 | CID011968896 | |
| Drug | AC1L1G72 | 2.14e-10 | 11 | 80 | 5 | CID000003553 | |
| Drug | LG 5 | 1.68e-09 | 60 | 80 | 7 | CID011840957 | |
| Drug | 4-Iodopyrazole | 4.18e-08 | 3 | 80 | 3 | DB02721 | |
| Drug | AC1L1B58 | 5.24e-08 | 29 | 80 | 5 | CID000001288 | |
| Drug | Fomepizole | 1.67e-07 | 4 | 80 | 3 | DB01213 | |
| Drug | Calcort | 2.16e-07 | 38 | 80 | 5 | CID000026709 | |
| Drug | 2-amino-5-methylpyridine | 3.02e-07 | 77 | 80 | 6 | CID000015348 | |
| Drug | YIGSR | 3.52e-07 | 79 | 80 | 6 | CID000123977 | |
| Drug | LMWH | VEGFC LAMB4 THBS1 ERBB3 VWF PNLIPRP1 LAMA1 LRP1 LAMA2 LAMC1 LAMC2 FST PROS1 | 5.05e-07 | 663 | 80 | 13 | CID000000772 |
| Drug | NSC 714187 | 5.45e-07 | 85 | 80 | 6 | CID005288693 | |
| Drug | Sikvav | 1.42e-06 | 24 | 80 | 4 | CID005487517 | |
| Drug | 2-butoxyethanol | 1.42e-06 | 24 | 80 | 4 | CID000008133 | |
| Drug | kalinin | 1.43e-06 | 55 | 80 | 5 | CID000032518 | |
| Drug | Ethanol | 1.45e-06 | 7 | 80 | 3 | DB00898 | |
| Drug | CC270 | 2.04e-06 | 59 | 80 | 5 | CID006918852 | |
| Drug | N-heptylformamide | 2.31e-06 | 8 | 80 | 3 | CID000347402 | |
| Drug | 2-NA | 3.46e-06 | 9 | 80 | 3 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 3.46e-06 | 9 | 80 | 3 | CID000440672 | |
| Drug | AC1L1AOQ | 3.61e-06 | 30 | 80 | 4 | CID000001082 | |
| Drug | AC1L1CUL | 4.92e-06 | 10 | 80 | 3 | CID000002070 | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 6.08e-06 | 197 | 80 | 7 | 3364_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; HL60; HT_HG-U133A | 6.28e-06 | 198 | 80 | 7 | 6146_UP | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A | 6.28e-06 | 198 | 80 | 7 | 2929_UP | |
| Drug | dysprosium | 6.29e-06 | 74 | 80 | 5 | CID000023912 | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 6.71e-06 | 200 | 80 | 7 | 2481_UP | |
| Drug | Paclitaxel | VEGFC CACNA2D1 ERBB2 TRAF1 FRAS1 ERBB3 FBN1 TNFRSF8 ENPP2 WIF1 LAMA2 EGFL6 | 7.68e-06 | 720 | 80 | 12 | ctd:D017239 |
| Drug | AC1L1J0I | 8.98e-06 | 12 | 80 | 3 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 8.98e-06 | 12 | 80 | 3 | CID000008104 | |
| Drug | CMF regimen | 1.16e-05 | 13 | 80 | 3 | ctd:C034456 | |
| Drug | 2-naphthaldehyde | 1.16e-05 | 13 | 80 | 3 | CID000006201 | |
| Drug | 3-methylbutanal | 1.16e-05 | 13 | 80 | 3 | CID000011552 | |
| Drug | Toxins, Biological | ERBB3 CSF3R CD27 PRF1 TNFRSF8 LAMA2 LAMC1 LAMC2 FST ATF2 ADH1C | 1.28e-05 | 632 | 80 | 11 | ctd:D014118 |
| Drug | 1,2-dimethylhydrazine | 1.32e-05 | 86 | 80 | 5 | CID000001322 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 1.47e-05 | 314 | 80 | 8 | CID000003542 | |
| Drug | naphthalenemethanol | 1.48e-05 | 14 | 80 | 3 | CID000020908 | |
| Drug | H-9 dihydrochloride | 1.64e-05 | 90 | 80 | 5 | CID000003544 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.79e-05 | 155 | 80 | 6 | 6817_DN | |
| Drug | germanium monoxide | 1.83e-05 | 92 | 80 | 5 | CID006327639 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 1.84e-05 | 15 | 80 | 3 | CID000440673 | |
| Drug | I-Q-S | 1.86e-05 | 156 | 80 | 6 | CID000003540 | |
| Drug | Rgd Peptide | 2.13e-05 | 239 | 80 | 7 | CID000104802 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.22e-05 | 161 | 80 | 6 | 3556_DN | |
| Drug | phenoxyethanol | 2.26e-05 | 16 | 80 | 3 | CID000031236 | |
| Drug | naphthaldehyde | 2.26e-05 | 16 | 80 | 3 | CID000006195 | |
| Drug | funiferine N-oxide | 2.65e-05 | 49 | 80 | 4 | CID000191631 | |
| Drug | quinocetone | 2.70e-05 | 248 | 80 | 7 | ctd:C502851 | |
| Drug | 2-acetamidoethanethiol | 3.65e-05 | 3 | 80 | 2 | ctd:C023704 | |
| Drug | C x F | 3.89e-05 | 19 | 80 | 3 | CID000013017 | |
| Drug | Peony | 4.56e-05 | 20 | 80 | 3 | CID005483934 | |
| Drug | Ethylene Glycol | 5.31e-05 | 21 | 80 | 3 | ctd:D019855 | |
| Drug | 4-iodopyrazole | 5.31e-05 | 21 | 80 | 3 | CID000077022 | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 5.62e-05 | 190 | 80 | 6 | 2911_UP | |
| Drug | Betamethasone-d5 | VEGFC CACNA2D1 LAMB4 PNLIPRP1 CD27 PRF1 ENPP2 LAMA1 LRP1 LAMA2 LAMC1 LAMC2 LTBP1 PROS1 STAB1 | 5.79e-05 | 1340 | 80 | 15 | CID000003003 |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 1501_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 3078_UP | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2533_UP | |
| Drug | cobalt-60 | 6.82e-05 | 390 | 80 | 8 | CID000061492 | |
| Drug | PHA665752 | 7.03e-05 | 23 | 80 | 3 | CID010461815 | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 4523_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 3626_UP | |
| Drug | EGFR/ErbB2 inhibitor | 7.28e-05 | 4 | 80 | 2 | CID009843206 | |
| Drug | perfluoro-n-undecanoic acid | 8.42e-05 | 402 | 80 | 8 | ctd:C101814 | |
| Drug | Smoke | THBS1 ERBB3 TMEM92 PRF1 LAMA1 SHISA2 LTBP1 FST TACSTD2 ATF2 NOTCH1 SORL1 | 1.01e-04 | 937 | 80 | 12 | ctd:D012906 |
| Drug | 4-methylpiperazine-2,6-dione | 1.02e-04 | 26 | 80 | 3 | CID000124723 | |
| Drug | fomepizole | 1.15e-04 | 27 | 80 | 3 | ctd:C010238 | |
| Drug | N-1-methylheptylformamide | 1.21e-04 | 5 | 80 | 2 | CID005478865 | |
| Drug | 3-hydroxyundecanoate | 1.21e-04 | 5 | 80 | 2 | CID003083221 | |
| Drug | 3-hydroxynonanoate | 1.21e-04 | 5 | 80 | 2 | CID000036599 | |
| Drug | trypanothione disulfide | 1.36e-04 | 140 | 80 | 5 | CID000115098 | |
| Drug | dobutamine | 1.36e-04 | 140 | 80 | 5 | CID000036811 | |
| Drug | Mifepristone | 1.38e-04 | 553 | 80 | 9 | ctd:D015735 | |
| Drug | dhmal | 1.43e-04 | 29 | 80 | 3 | CID000151725 | |
| Drug | sulfate | CACNA2D1 LAMB4 ERBB2 THBS1 ERBB3 VWF PNLIPRP1 MTHFD1 ENPP2 LAMA1 LAMA2 LAMC1 LAMC2 FST | 1.49e-04 | 1292 | 80 | 14 | CID000001117 |
| Drug | Cimetidine | 1.50e-04 | 76 | 80 | 4 | ctd:D002927 | |
| Drug | taxol | 1.52e-04 | 560 | 80 | 9 | CID000004666 | |
| Drug | Methanol | 1.75e-04 | 31 | 80 | 3 | ctd:D000432 | |
| Drug | caroverine | 1.81e-04 | 6 | 80 | 2 | CID000065709 | |
| Drug | ZD-6 | 1.81e-04 | 6 | 80 | 2 | CID010062753 | |
| Drug | AC1NAG0I | 1.93e-04 | 32 | 80 | 3 | CID004476319 | |
| Drug | willardine | 1.93e-04 | 32 | 80 | 3 | CID000005123 | |
| Drug | walrycin A | 1.93e-04 | 32 | 80 | 3 | ctd:C574123 | |
| Drug | Raloxifene Hydrochloride | ERBB2 THBS1 ERBB3 VWF ENPP2 LAMC1 SHISA2 LTBP1 FST PROS1 ADH1C | 1.97e-04 | 857 | 80 | 11 | ctd:D020849 |
| Drug | Grgds | 2.10e-04 | 83 | 80 | 4 | CID000123811 | |
| Drug | triphenyltin | 2.11e-04 | 33 | 80 | 3 | ctd:C030665 | |
| Drug | CPPG | 2.31e-04 | 34 | 80 | 3 | CID000002878 | |
| Drug | diethyl malate | 2.41e-04 | 86 | 80 | 4 | ctd:C058705 | |
| Drug | 3-butylthiolane 1-oxide | 2.53e-04 | 7 | 80 | 2 | CID003363251 | |
| Drug | NSC98537 | 2.56e-04 | 473 | 80 | 8 | CID000005410 | |
| Drug | DOPEG | 2.74e-04 | 36 | 80 | 3 | CID000091528 | |
| Drug | 3,4-diaminopyridine | 3.22e-04 | 38 | 80 | 3 | CID000005918 | |
| Drug | Ikvav | 3.22e-04 | 38 | 80 | 3 | CID000131343 | |
| Drug | AC1O0B8G | 3.23e-04 | 262 | 80 | 6 | CID000091605 | |
| Drug | 5-butyl-2-phenoxyphenol | 3.37e-04 | 8 | 80 | 2 | CID005274975 | |
| Drug | Folfox protocol | 3.37e-04 | 8 | 80 | 2 | ctd:C410216 | |
| Drug | 3-keto-LCA | 3.37e-04 | 8 | 80 | 2 | CID000159623 | |
| Drug | AC1NBLOP | 3.37e-04 | 8 | 80 | 2 | CID004469995 | |
| Drug | L-745,870 | 3.37e-04 | 8 | 80 | 2 | CID005311200 | |
| Drug | 2-Propanol | 3.48e-04 | 39 | 80 | 3 | ctd:D019840 | |
| Drug | ivabradine | 3.48e-04 | 39 | 80 | 3 | CID000132999 | |
| Disease | cortical thickness | SP8 ZBTB34 THBS1 ERBB3 FBN1 ENPP2 ZNF423 LAMA1 LRP1 LAMA2 ADAMTS18 CUL9 LAMC1 STAB1 | 1.37e-06 | 1113 | 79 | 14 | EFO_0004840 |
| Disease | Disease Exacerbation | 5.54e-06 | 165 | 79 | 6 | C0235874 | |
| Disease | laminin subunit gamma-2 measurement | 7.08e-06 | 2 | 79 | 2 | EFO_0801756 | |
| Disease | urinary bladder cancer (is_marker_for) | 1.04e-05 | 107 | 79 | 5 | DOID:11054 (is_marker_for) | |
| Disease | cutis laxa (implicated_via_orthology) | 2.12e-05 | 3 | 79 | 2 | DOID:3144 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | VEGFC ERBB2 THBS1 ERBB3 KMT2D VWF PNLIPRP1 LAMA2 FST ATF2 NOTCH1 SORL1 | 2.75e-05 | 1074 | 79 | 12 | C0006142 |
| Disease | stomach carcinoma (is_marker_for) | 3.59e-05 | 24 | 79 | 3 | DOID:5517 (is_marker_for) | |
| Disease | Non-alcoholic Fatty Liver Disease | 3.81e-05 | 70 | 79 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 3.81e-05 | 70 | 79 | 4 | C3241937 | |
| Disease | cutis laxa (is_implicated_in) | 4.23e-05 | 4 | 79 | 2 | DOID:3144 (is_implicated_in) | |
| Disease | juvenile idiopathic arthritis | 4.75e-05 | 74 | 79 | 4 | EFO_0002609 | |
| Disease | aortic measurement | 5.90e-05 | 251 | 79 | 6 | EFO_0020865 | |
| Disease | Geleophysic dysplasia | 7.04e-05 | 5 | 79 | 2 | C3489726 | |
| Disease | Alcohol dependence | 7.04e-05 | 5 | 79 | 2 | cv:C0001973 | |
| Disease | Acromicric Dysplasia | 7.04e-05 | 5 | 79 | 2 | C0265287 | |
| Disease | ALCOHOL DEPENDENCE | 7.04e-05 | 5 | 79 | 2 | 103780 | |
| Disease | intestinal cancer (implicated_via_orthology) | 8.66e-05 | 32 | 79 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | VEGFC FRAS1 ERBB3 FBN1 LRP1 LAMC2 LTBP1 LTBP3 FST LTBP4 NPNT SORL1 | 9.96e-05 | 1228 | 79 | 12 | EFO_0004713 |
| Disease | nephroblastoma (is_marker_for) | 1.04e-04 | 34 | 79 | 3 | DOID:2154 (is_marker_for) | |
| Disease | Cutis Laxa | 1.05e-04 | 6 | 79 | 2 | C0010495 | |
| Disease | Colorectal Carcinoma | 1.08e-04 | 702 | 79 | 9 | C0009402 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | 1.34e-04 | 37 | 79 | 3 | EFO_0004276, EFO_0004775, EFO_0006997 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.34e-04 | 37 | 79 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 1.36e-04 | 97 | 79 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | Lymphoma | 1.70e-04 | 40 | 79 | 3 | C0024299 | |
| Disease | Congenital small ears | 1.83e-04 | 41 | 79 | 3 | C0152423 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 1.96e-04 | 8 | 79 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Alcohol Use Disorder | 2.26e-04 | 44 | 79 | 3 | C0001956 | |
| Disease | Marfan Syndrome, Type I | 2.52e-04 | 9 | 79 | 2 | C4721845 | |
| Disease | alcohol use disorder measurement | 2.79e-04 | 214 | 79 | 5 | EFO_0009458 | |
| Disease | aortic aneurysm | 3.14e-04 | 10 | 79 | 2 | EFO_0001666 | |
| Disease | Head and Neck Carcinoma | 3.14e-04 | 10 | 79 | 2 | C3887461 | |
| Disease | pulse pressure measurement | TRAF1 FBLN5 FBN1 ENPP2 ZNF423 LRP1 LTBP1 LTBP3 NSD3 NPNT ADH1B ADH1C | 3.17e-04 | 1392 | 79 | 12 | EFO_0005763 |
| Disease | acne | 3.61e-04 | 125 | 79 | 4 | EFO_0003894 | |
| Disease | gallbladder neoplasm | 3.83e-04 | 11 | 79 | 2 | C0016978 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.83e-04 | 11 | 79 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Marfan Syndrome | 3.83e-04 | 11 | 79 | 2 | C0024796 | |
| Disease | Malignant neoplasm of gallbladder | 3.83e-04 | 11 | 79 | 2 | C0153452 | |
| Disease | Malignant Neoplasms | 3.95e-04 | 128 | 79 | 4 | C0006826 | |
| Disease | alcohol dependence measurement | 4.38e-04 | 55 | 79 | 3 | EFO_0007835 | |
| Disease | Amelogenesis Imperfecta | 4.59e-04 | 12 | 79 | 2 | C0002452 | |
| Disease | alcohol consumption measurement, alcohol drinking | 4.59e-04 | 12 | 79 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | isoleucine measurement | 4.62e-04 | 56 | 79 | 3 | EFO_0009793 | |
| Disease | Mammary Carcinoma, Human | 5.21e-04 | 525 | 79 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.21e-04 | 525 | 79 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 5.33e-04 | 527 | 79 | 7 | C1458155 | |
| Disease | Bladder Neoplasm | 5.54e-04 | 140 | 79 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 5.69e-04 | 141 | 79 | 4 | C0005684 | |
| Disease | Breast Carcinoma | 6.02e-04 | 538 | 79 | 7 | C0678222 | |
| Disease | median neuropathy (biomarker_via_orthology) | 6.31e-04 | 14 | 79 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 6.85e-04 | 550 | 79 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 7.27e-04 | 15 | 79 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 7.27e-04 | 15 | 79 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 7.27e-04 | 15 | 79 | 2 | C0154091 | |
| Disease | alcohol use disorder (is_implicated_in) | 8.29e-04 | 16 | 79 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | prostate cancer (is_marker_for) | 8.30e-04 | 156 | 79 | 4 | DOID:10283 (is_marker_for) | |
| Disease | pulse pressure measurement, alcohol drinking | 8.89e-04 | 70 | 79 | 3 | EFO_0004329, EFO_0005763 | |
| Disease | cortical surface area measurement | SP8 CACNA2D1 THBS1 ERBB3 FBN1 ENPP2 ZNF423 LAMA2 ADAMTS18 CUL9 LAMC1 | 8.89e-04 | 1345 | 79 | 11 | EFO_0010736 |
| Disease | cardiomyopathy (implicated_via_orthology) | 9.26e-04 | 71 | 79 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 9.38e-04 | 17 | 79 | 2 | C0153943 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 9.38e-04 | 17 | 79 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 9.38e-04 | 17 | 79 | 2 | C0496905 | |
| Disease | erythritol measurement | 9.38e-04 | 17 | 79 | 2 | EFO_0021171 | |
| Disease | Carcinoma in situ of stomach | 9.38e-04 | 17 | 79 | 2 | C0154060 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 9.38e-04 | 17 | 79 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | p-tau measurement | 9.64e-04 | 72 | 79 | 3 | EFO_0004763 | |
| Disease | Carcinoma of bladder | 1.05e-03 | 18 | 79 | 2 | C0699885 | |
| Disease | Hypertriglyceridemia | 1.18e-03 | 19 | 79 | 2 | EFO_0004211 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.18e-03 | 19 | 79 | 2 | DOID:2876 (is_marker_for) | |
| Disease | factor VIII measurement, Ischemic stroke | 1.18e-03 | 19 | 79 | 2 | EFO_0004630, HP_0002140 | |
| Disease | Esophageal Neoplasms | 1.22e-03 | 78 | 79 | 3 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 1.22e-03 | 78 | 79 | 3 | C0546837 | |
| Disease | Stomach Neoplasms | 1.23e-03 | 297 | 79 | 5 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.28e-03 | 300 | 79 | 5 | C0024623 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.30e-03 | 20 | 79 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Stomach Carcinoma | 1.44e-03 | 21 | 79 | 2 | C0699791 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 1.44e-03 | 21 | 79 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | waist-hip ratio | 1.58e-03 | 1226 | 79 | 10 | EFO_0004343 | |
| Disease | Nasopharyngeal carcinoma | 1.58e-03 | 22 | 79 | 2 | C2931822 | |
| Disease | clinical and behavioural ideal cardiovascular health | 1.73e-03 | 23 | 79 | 2 | EFO_0007654 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 1.88e-03 | 24 | 79 | 2 | EFO_0009458, MONDO_0007079 | |
| Disease | apolipoprotein A 1 measurement | 1.95e-03 | 848 | 79 | 8 | EFO_0004614 | |
| Disease | parental emotion expression measurmement, conduct disorder | 2.04e-03 | 25 | 79 | 2 | EFO_0004216, EFO_0008342 | |
| Disease | Squamous cell carcinoma of esophagus | 2.14e-03 | 95 | 79 | 3 | C0279626 | |
| Disease | Heart valve disease | 2.21e-03 | 26 | 79 | 2 | C0018824 | |
| Disease | brain cancer (implicated_via_orthology) | 2.21e-03 | 26 | 79 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | 2.26e-03 | 869 | 79 | 8 | EFO_0004735 | |
| Disease | intraocular pressure measurement | 2.46e-03 | 509 | 79 | 6 | EFO_0004695 | |
| Disease | corpus callosum volume measurement | 2.48e-03 | 100 | 79 | 3 | EFO_0010299 | |
| Disease | obesity (is_marker_for) | 2.55e-03 | 101 | 79 | 3 | DOID:9970 (is_marker_for) | |
| Disease | mosquito bite reaction size measurement | 2.56e-03 | 212 | 79 | 4 | EFO_0008378 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.56e-03 | 28 | 79 | 2 | DOID:5409 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RCKGPLPTDCCHEQC | 226 | P04626 | |
| VKDNGRSCPPCHEVC | 176 | P21860 | |
| CSQDVNECGMKPRPC | 91 | Q8IUX8 | |
| QCRDKECTECDPLPN | 111 | P26842 | |
| NPFKCEDPCEGENKC | 641 | Q5JQC9 | |
| PQCGKCRICKNPESN | 96 | P07327 | |
| PQCGKCRVCKNPESN | 96 | P00325 | |
| PQCGKCRICKNPESN | 96 | P00326 | |
| NCQCFPGHRPPDCKF | 641 | Q9Y3Q7 | |
| PEFQDSCGCLKCPNR | 4316 | Q86UQ4 | |
| DDKPFLCTAPGCGQR | 21 | P15336 | |
| PCNCDVSKGFDPDCN | 1886 | Q9HCU4 | |
| PCSPNKNDVCIDGVC | 706 | Q8TE60 | |
| PFCPDCGNKFSIRNR | 161 | Q9H1K0 | |
| RCQDPNPCLSTPCKN | 56 | P46531 | |
| QCQGPHECTRCKGPF | 1011 | Q86XX4 | |
| HSCGQVCEREFKPPC | 251 | Q6ZNB6 | |
| GECPRSGKRFCPCQK | 386 | Q6ZNB6 | |
| CNQDLNECGLKPRPC | 86 | Q6UXI9 | |
| NLLESEDCKLPCNPC | 406 | O76014 | |
| PSDRFKCENNRCIPN | 896 | Q07954 | |
| NLLESEDCKLPCNPC | 406 | O76015 | |
| QGCPFCRCEIKGTEP | 406 | Q13191 | |
| PSCGLCLKADPRFNC | 791 | P51805 | |
| SDKCFPCPDQGCPQM | 311 | P54315 | |
| GQCSSRDKCQCPPNF | 411 | Q14766 | |
| RDKCQCPPNFTGKLC | 416 | Q14766 | |
| FDENLPCKRGCFCPE | 1206 | Q7Z5P9 | |
| QKSPRDPCQCVCHGS | 386 | P14222 | |
| CPLDPATNKSRCECE | 296 | P24043 | |
| SKNEDPCFGPCICKE | 476 | P24043 | |
| NNCDPKTGRCICPPN | 1021 | P24043 | |
| CCARCNTPPNLKGRY | 326 | Q9HCJ2 | |
| FNGGAPNCIPCKETC | 81 | P19883 | |
| KNKPRCVCAPDCSNI | 111 | P19883 | |
| GNCPLTCDLCNKGFI | 556 | Q9NQV6 | |
| RTLINPKPCGQFCCC | 296 | O94886 | |
| CNQERIPFTCPCKDG | 3916 | Q9Y4D8 | |
| KDPYSRGDPCNTICC | 461 | Q6P4A8 | |
| AKFDPCQCAPCPNNG | 516 | P13671 | |
| RDPCAGPVCDCKRNS | 831 | P54289 | |
| ECLLEPRKCAPGTCQ | 1976 | P35555 | |
| PRCGNKIYNPSEQCC | 41 | Q6UXB1 | |
| DCVPKDGQSHCCIPR | 176 | Q99062 | |
| ECRDPSSCPDGKCEN | 706 | Q9NS15 | |
| CCEGNICNLPLPRNE | 121 | Q86Y78 | |
| ACKNLPGSFRCVCPA | 686 | Q8N2S1 | |
| IPCDCNRAGTQKPIC | 1126 | A4D0S4 | |
| PGCQECPACYRLVKD | 1026 | P11047 | |
| PLAPNPADKCRACNC | 561 | Q13753 | |
| CPSCQAPIEKNEGCL | 2236 | Q8IWT3 | |
| RCMCPAENPGCRDQP | 331 | Q9UBX5 | |
| NDCFIPCTPKGCLEL | 141 | P11586 | |
| LQEAGPPDCRCDNLC | 66 | Q13822 | |
| RCPECAKVFSCPANL | 296 | Q01101 | |
| AAAQPLPDCCRQKTC | 31 | O43612 | |
| CNCGRKQAPRDDPFD | 611 | Q8ND04 | |
| DPVNCEKKCNGFRCP | 1231 | Q92673 | |
| PDCDPEGRFKARQCN | 106 | P09758 | |
| ACPQSLPCFEESDCK | 6 | Q6NSW7 | |
| GACPCKENVFGPQCN | 1116 | P25391 | |
| AACCCRCLRPKQDPQ | 136 | Q6UWI4 | |
| ETCYNPKGLCVLCPN | 136 | Q5MNZ6 | |
| RGCPLCPDDCPAQMQ | 161 | Q9BRJ9 | |
| VCKNIPGDFECECPE | 216 | P07225 | |
| TCDCPNCQEAERLGP | 331 | Q8IXZ3 | |
| AKCFCRNCREPEPDS | 76 | Q6UXU6 | |
| RDGQVQCLNCPEPKC | 256 | Q9UBS8 | |
| CNKQDCPIDGCLSNP | 541 | P07996 | |
| QPLNPGKCACECTES | 351 | P49767 | |
| KPFECPVEGCCARFS | 416 | Q2QGD7 | |
| CKDPPGDDCGNSVCL | 241 | P17040 | |
| DERGDCVPKAQCPCY | 696 | P04275 | |
| PGECRPNFTCACRKE | 2351 | P04275 | |
| PQCCPLCQQDLGSRK | 26 | H3BPM6 | |
| KFCQCNPDCQNRFPG | 546 | Q92800 | |
| NPDCQNRFPGCRCKT | 551 | Q92800 | |
| NIPGACCPVCLQKRA | 1461 | Q92626 | |
| QPCPEGSGDCRKQCE | 231 | P28908 | |
| VCQDPKEPRALCCAG | 26 | Q13077 | |
| CAKKIQVPDCCPGFF | 1311 | Q9NY15 | |
| CDQKITSPQCPRKCD | 1411 | Q9NY15 | |
| EQCEISKCPQPCRNG | 271 | Q9Y5W5 | |
| PRCNCKPADENPCGL | 1096 | Q9BZ95 | |
| CLPNPGTFEECHRKC | 76 | O96008 | |
| PCAGLRCPECSVKFE | 1116 | Q2M1K9 | |
| GEKPFQCPQCDRCFR | 326 | Q6IV72 | |
| KPFRCEICGKCFPFQ | 426 | Q8NCN2 | |
| PECKVCQACRKPGND | 271 | O14686 |